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ABSTRACT 
A novel application of Monte Carlo permutation testing that improves the calculation of the 
peptide match significance levels and detection rate in database search programs is demonstrated. 
Novel k-permuted decoy databases (where k denotes the type and number of permutations) were 
evaluated for accurate computation of match significance levels. K-permuted decoy databases were 
generated by: (a) complete permutations of peptide sequences (Whole), (b) permutation of terminal 
positions of peptide sequences (End), and (c) permuted peptides that fall within a certain mass 
tolerance of the tandem mass spectra (Mass-based). The ‘Whole’ and ‘End’ based permutation 
tests were performed using various indicators of peptide match quality in OMSSA, Crux, and X! 
Tandem on manually annotated neuropeptide tandem mass spectrometry spectra. Permutation p-
values were calculated as the fraction of the permutations in the k-permuted databases with match 
indicator score as extreme as the original spectra match in the target database. The ‘Whole’ k-
permuted decoy databases identified most (up to 100%) neuropeptides, while the ‘End’ k-permuted 
decoy databases provided better discrimination of the performance between the match indicators. 
The permutation test based p-values using the hyperscore (X! Tandem), E-value (OMSSA) and Sp 
score (Crux) match indicators outperformed the other match indicators in the database search 
programs. The simple indicator of match “the number of matched ions” provided performance 
comparable to the best match indicators in the OMSSA, X! Tandem, and Crux.  Databases of least 
10
5
 k-permuted decoy peptides per spectra provided accurate p-values. Overall, the ‘Whole’ and 
‘End’ k-permuted decoy databases improved the consensus among the database search programs. 
  iii 
The ability of the k-permuted decoy databases to improve the classifications among correct 
and incorrect peptide matches was evaluated with ‘Mass-based’ k-permuted decoy database using 
best match indicator in the OMSSA (i.e., E-value). The evaluation was performed by searching 
5806 tryptic tandem mass spectra (671 with annotated peptide entries) against the standard target 
and combined target-decoy databases. False discovery rate estimates based on the target-decoy 
approach and known identities of the annotated spectra were used to filter the peptide-spectrum 
matches. The k-permuted decoy database approach enabled the detection of up to 89% and 87% 
annotated peptides relative to the OMSSA’s E-value with 82% and 84% identifications in the 
target database and target-decoy database, respectively. Improvements in performance was due to 
better performance of the k-permutation decoy database on small and large peptides with less than 
13 matched fragment ions and large (insignificant) OMSSA E-values.  
  iv 
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CHAPTER I: LITERATURE REVIEW 
1.1 NEUROPEPTIDES 
Neuropeptides are a complex class of endogenous peptides containing both 
neurotransmitters and peptide hormones.
1
 Neuropeptides perform multiple functions including 
communication between cells, and regulation of various biological processes such as growth, 
memory, learning, behavior, sleep, and circadian rhythms.
1, 2
 Neuropeptides are present in the 
central nervous system and peripheral organs including pancreas, adrenal gland, and in the immune 
system.
3
 Given the same primary amino acid sequence, some neuropeptides can act both as 
neurotransmitter and as a peptide hormone. Neuropeptides are functionally active molecules that 
are derived from larger inactive precursor proteins known as prohormones after complex 
proteolytical processing. A prohormone may contain one copy of the neuropeptide, multiple copies 
of the same neuropeptide, or multiple distinct neuropeptides.
1
 
Most prohormones follow a common mechanism for the proteolytic processing.
1
 
Prohormones include an N-terminal signal peptide that guides the sequence through the ribosome 
and into the lumen of rough endoplasmic reticulum. Here, the signal peptide is cleaved by the 
signal peptidase enzymes followed by the transfer to the trans-Golgi apparatus. In the Golgi 
apparatus, the prohormones are packed into the secretory vesicles along with various processing 
enzymes.
4, 5
 Formation of functionally active neuropeptides from prohormones in the secretory 
vesicles is a multi-step process. First, endoproteolytic cleavage by convertase enzymes generates 
intermediate neuropeptides. This cleavage occurs C-terminal from the dibasic or multiple basic 
residues (i.e., lysine or arginine), or less frequently from single basic residues, or rarely on from 
 2 
 
non-basic residues.
6
 Other factors that can influence the processing of prohormones into 
neuropeptides include the organism developmental stage and the environment such as pH.
7
 
Second, C-terminal basic residues are removed from the intermediate neuropeptides by the 
carboxypeptidases enzymes. Previous studies have shown that defects in the prohormone 
processing and failure to remove basic residues leads to obesity in humans and rodents.
8, 9
 Third, 
the neuropeptides undergo further post-translational modifications (PTMs) including acetylation, 
phosphorylation, and amidation.
1, 10
 Figure 1.1 depicts the steps involved in neuropeptide 
processing. N- and C-terminal PTMs are the most common among neuropeptides and are 
important for optimal functional activity and low degradation of the neuropeptides.
6
 
The resulting neuropeptides that are released into extracellular space are short in length, 
usually ranging between 3-40 amino acids.
1
 Neuropeptides interact with G-protein coupled 
receptors located on the surface of the target cells. The receptors consist of seven membrane 
spanning alpha helices. The binding of the neuropeptide to the G-protein coupled receptors 
changes its conformation leading to activation of coupled G-protein, which then mediates 
intercellular signal transduction. So far approximately 100 different neuropeptide receptors have 
been reported in C. elegans.
11
  
Several methods are available to identify neuropeptides from the biological samples 
including: Edman degradation, immunocytochemistry, enzyme-linked immunosorbent assay 
(ELISA), radioimmunoassay (RIA), and mass spectrometry (MS). Among these methods, MS has 
gained much popularity for the peptide and protein identification. 
 3 
 
1.2 MASS SPECTROMETRY BASED PROTEOMICS AND PEPTIDOMICS 
The disciplines of Proteomics and Peptidomics deal with the characterization of protein and 
peptide content within an organ, tissue or cell of the organisms, respectively.
12
 MS is an analytical 
technique that has gained much popularity for the analysis of proteins and peptides present in the 
complex biological samples mainly due to improvement in separation techniques, availability of 
sequence databases, and soft ionization techniques (that transmit little residual energy onto the 
molecules to avoid too much degradation of molecules) such as electrospray ionization (ESI) and 
matrix assisted laser desorption ionization (MALDI).
13
 
A mass spectrometer contains three regions: an ion source, a mass analyzer, and a detector 
region. The ion source converts proteins or peptides in a sample into ions for MS analysis. ESI and 
MALDI are the two common methods that vaporize the molecules out of solution and dry samples, 
respectively. ESI coupled with MS is most commonly used for complex protein mixtures, while for 
large number of relatively simple protein mixtures MALDI-MS is used. The mass analyzer region 
measures mass-to-charge (m/z) ratio of the ionized molecules. Various types of mass analyzers are 
available for the proteomic research that differs from each other in terms of sensitivity, mass 
resolution, mass accuracy, and ability to generate informative mass spectra. The basic types of 
mass analyzers include ion trap, time-of-flight, quadrupole, and Fourier transform ion cyclotron. 
The detector region determines the intensity value associated with each m/z value.
13
 
Figure 1.2 shows an overview of the tandem mass spectrometry. A tandem mass 
spectrometer contains more than one mass analyzer regions that are separated by the collision 
chambers.
13
 Upon injection of sample into the mass spectrometer, the ion source converts 
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molecules into ions that are analyzed by the first mass analyzer and an MS spectrum is generated 
that contains m/z values of the peptide ions and their relative abundance. The selected peptide ions 
undergo further fragmentation to generate a MS/MS or MS2 spectrum that contains information 
about the primary structure of the peptides.
13, 14
 The downstream analysis of MS or MS/MS spectra 
provides information about the identity of the peptides or proteins. In MS-based analysis, 
characterization of the protein of interest is conducted either through bottom up approach or top 
down approach.
14, 15
 Neuropeptides are endogenous peptides that are already present in the sample 
and do not require sample preparation by enzymatic digestion (bottom up approach) or MS-based 
fragmentation (top down approach) of proteins.
16
 However, due to their typical short length the 
performance of the database search programs was tested on neuropeptides such that these peptides 
can be generated in the course of some protein experiments by protein digestion or fragmentation. 
Hence such approaches are described briefly.  
TOP-DOWN APPROACH 
In the top down approach, proteins in the complex mixture are separated and then intact 
proteins are subjected to ionization by ESI or MALDI. The ionized proteins are fragmented by MS 
to generate fragment ions. This provides molecular masses of both intact proteins and their 
fragment ions that can be used to identify protein of interest with more complete amino acid 
sequence coverage and information about PTMs.
15
 For the top down approach, the fragmentation 
methods such as electron capture dissociation (ECD) and electron transfer dissociation (ETD) are 
more effective in fragmenting large peptides and proteins.
14, 15
 Provided enough number of 
fragment ions are detected in MS for the protein of interest, the top down approach enables 
 5 
 
identification of protein isoforms in much better fashion due to better sequence coverage.
14, 15
 
Furthermore, protein quantification using the top down approach is more reliable because 
abundance of proteins is measured directly rather than estimating it from the abundance of 
constituent peptides.
14
 Another advantage of the top down approach is that the masses of intact 
proteins are dispersed over a wider mass range unlike the peptide mixture obtained from the 
enzymatic digestion of proteins, thus reducing the complexity associated with the requirement to 
separate peptides prior to MS/MS analysis.
17
 Drawbacks of the top down approach include 
limitations associated with the separations methods, low sensitivity, and need for the large volumes 
of the sample relative to the bottom up approach.
14
 The masses of intact proteins and their 
fragments ions are queried against the proteomic databases
18
 or de novo approach can be used to 
identify the protein.
14
  
BOTTOM-UP APPROACH 
The bottom up approach is most commonly used to identify proteins present in complex 
biological samples in high throughput experiments. This approach starts with the protein 
purification step that is carried out either using gel based methods or gel free methods.
14
 The 
separated proteins are enzymatically digested to generate complex set of peptides. Among several 
proteases, trypsin is most commonly used that digests proteins at carboxyl-terminus of arginine or 
lysine residues unless these are followed by the proline residue. The resulting peptides mixture is 
separated using single or multidimensional separation techniques. The separated peptides are 
ionized by MS using ESI or MALDI ionization sources to generate peptide ions.
15, 19
 The mass 
analyzer region of the MS records the m/z values of the peptide ions (producing MS spectra).
13
 In 
 6 
 
bottom up studies mostly the peptide ions are further fragmented in tandem MS by Collision 
Induced Dissociation (CID) to generate product or fragment ions containing information about 
amino acid sequence and PTMs.
14
 Figure 1.3 depicts the general scheme of a typical bottom up 
experiment. 
The bottom up approach has several advantages over the top down approach for the large 
scale protein identifications. The bottom up can deal with samples of high complexity and the 
peptides resulting from the enzymatic digestion are more easily separated than the intact proteins 
with the current front end separation techniques. Furthermore, bottom up needs lesser volume of 
the sample and is widely used for the quantification of peptides and proteins through chemical 
modifications of peptides with techniques such as ICAT or O
18
 labeling. However, quantification 
using the top down approach is more reliable.
14
  
Several limitations are also associated with the bottom up approach. The digestion of 
proteins with enzyme such as trypsin results in peptides that fall within a relatively narrow mass 
range, which increases the difficulty to isolate these individual peptides for the downstream 
analysis.
17
 Another challenge is the under sampling of peptides representing less abundant proteins 
and mostly proteins with high abundance are detected.
20
 In the bottom up approach not all peptides 
from a single protein sequence are detected (usually 50-90% are detected) which leads to limited 
protein sequence coverage, which makes it less ideal choice to identify splice variants and PTMs.
21
 
Typically, only few peptides that provide sufficient information are used to identify the parent 
proteins in the bottom up analysis.
15
 
 7 
 
Various computational methods are available to identify protein sequences using MS or 
MS/MS spectral data. For the MS scan, Peptide Mass Fingerprinting (PMF) can be used to identify 
the protein of interest by comparing masses of observed peptides with the masses of peptides 
generated from each protein sequence in the database. However, PMF is useful when the sample 
only contains pure proteins.
17
 For the MS/MS data, the sequence database searching is the most 
efficient method to identify peptides. The magnitude of the correlation between the experimental 
and theoretical spectra in the database receives a statistical significance p- or E-value. 
Subsequently peptides are used to identify the precursor proteins by peptide-protein mapping and 
statistical confidence scores are assigned to peptide-protein mappings.
22
 Several databases include 
information that can be used by the database search and spectral library search approaches. 
1.3 DATABASES OF PROHORMONES AND NEUROPEPTIDES SEQUENCE AND 
SPECTRAL DATA 
UNIPROT 
UniProt (http://www.uniprot.org) is an integrated resource to store information pertaining 
to protein sequences and their functional annotation from various sources. The UniProt is a joint 
effort of research groups in the European Bioinformatics Institute (EBI), Protein Information 
Resource (PIR), and Swiss Institute of Bioinformatics (SIB).
23, 24
 UniProt has four components: 
UniProt Knowledgebase (UniProtKB) is a central repository to store curated information about 
proteins along with cross-references to more than 140 databases providing additional or 
complementary information on the annotation.
24
 UniProt Archive (UniParc) keeps track of changes 
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in the protein sequences present in the UniProt database. UniProt Reference Clusters (UniRef) 
clusters sequences in related species based on similarity to increase speed of searches. UniProt 
Metagenomic and Environmental sequences (UniMES) provide metagenomic and environmental 
data. The protein and peptide sequences from the UniProtKB were used in these studies. 
The UniProtKB has two different components: UniProtKB/Swiss-Prot and 
UniProtKB/TrEMBL. The UniProtKB/Swiss-Prot contains manually curated protein sequences 
and annotations that are extracted from literature and computational analysis. For each protein the 
following information is provided: function, enzyme specificity, functional domains, PTMs, 
subcellular location, tissue specificity, spliced isoforms, structure, interactions, and associated 
diseases.
23
 The current version of UniProtKB/Swiss-Prot (release 2013_10; October 16, 2013) 
contains 541,561 sequences obtained from 223,284 references. The UniProtKB/TrEMBL contains 
protein sequences that are computationally annotated and classified. The sequences that are 
translated from the coding sequences (CDS) present in the EMBL, GenBank, DDBJ nucleotide 
sequence databases, sequences associated with PDB structures, and data derived from the 
sequences directly submitted to UniProtKB and published literature.
23
 Currently 
UniProtKB/TrEMBL (release 2013_10; October 16, 2013) contains 44,746,523 protein sequence 
records. 
SWEPEP 
SwePep (http://www.swepep.org) is a composite database of neuropeptide sequences and 
tandem spectral data designed to facilitate peptide identification in mass spectrometry 
 9 
 
experiments.
25
 The sequence database contains 4,180 annotated endogenous peptides and small 
proteins that are less than 10 KDa from 394 different species. These endogenous peptides were 
collected from three sources: in house experimentally verified peptides, peptides and proteins from 
UniProt, and peptides and proteins extracted from peer-reviewed publications. SwePep provides 
the calculated monoisotopic mass, average isotopic mass and isoelectric point (PI) for each peptide 
sequence in the database. The peptides in SwePep are classified into three groups: (1) biologically 
active peptides, the peptides with known biological functions; (2) potential biologically active 
peptides, the peptides with unknown biological function that belong to known peptide precursor 
proteins containing endogenous peptide specific processing sites; and (3) uncharacterized peptides, 
all peptides that do not belong to the above two groups. The SwePep sequence database is 
searchable by using the peptide’s mass or name, organism name, or UniProt accession number.25 
The spectral library of the SwePep includes CID spectra obtained from the LTQ mass spectrometer 
coupled with liquid chromatography and ESI.
26
 The 389 unique peptide identifications from 2,700 
tandem spectra using X! Tandem were included in the spectral library regardless of the score 
threshold (loge(-2)). The spectral library is searchable using peptide sequence and peptide 
molecular mass with adjustable mass tolerance. 
NATIONAL INTITUTE OF STANDARDS AND TECHNOLOGY (NIST) 
NIST (http://peptide.nist.gov) hosts a tandem spectral library of tryptic peptides produced 
in LC-MS/MS experiments utilizing the ESI method. The library generally holds spectra from ion 
trap and quadrupole-TOF mass spectrometers. The tandem spectra in NIST are grouped into three 
categories: 1) the consensus spectra; 2) the best replicate spectra; and 3) the high confidence single 
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spectra identifications. Utilizing four database search programs the peptides were peptide 
sequences were assigned to every spectrum.
27
 
NEUROPEDIA 
NeuroPedia is a neuropeptide sequence and spectral library 
(http://proteomics.ucsd.edu/Software/NeuroPedia/index.html).
28
 NeuroPedia was developed to 
improve the sensitivity and speed of the sequence database search and spectral library search 
programs in neuropeptide studies. The NeuroPedia sequence database contains 847 neuropeptides 
obtained from seven species, human (270), rat (195), mouse (188), bovine (154), rhesus macaque 
(20), chimpanzee (17), California sea hare (2), and leech (1). The 847 neuropeptides (from 332 
precursor proteins) ranged in length from 2 to 1,129 amino acids in length. Neuropeptide 
description available in NeuroPedia includes peptide sequence, name, gene family, organism name, 
taxonomy, gene name, RefSeq gene identifier, protein name, RefSeq protein identifier, UniProt 
accession number, and start and end positions of the neuropeptide in the precursor protein. The 847 
sequences are clustered into three groups regardless of the species based on sequence similarity in 
pairwise alignments: (1) 531 identical pairs, when the two aligned peptide sequences are exactly 
similar or redundant; (2) 5,020 overlapping pairs, with two aligned sequences identical up to half 
the length of the longest sequence in the alignment; and (3) 9,185 homolog pairs, with aligned 
sequences including one or two amino acid substitutions. The NeuroPedia spectral library contains 
3,401 tandem spectra gathered from the NIST library and in house experimental datasets from five 
species, human (3,184), bovine (145), mouse (67), rat (4), and leech (1). The tandem spectral 
library is downloadable in the Mascot Generic Format (MGF) and is compatible with MSPLIT
29
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spectral library search program. The 3,401 tandem spectra are divided into ten MGF files 
depending upon the source organism (five species), instrument type (ion trap or quadrupole time of 
flight), and enzyme specificity (trypsin, v8, or none). Furthermore, the NeuroPedia allows visual 
inspection of each tandem spectrum. 
PEPTIDEDB 
PeptideDB (http://www.peptides.be) is a sequence database composed of biologically 
active endogenous peptides, precursor proteins and known protein motifs.
30
 The current version of 
the database (version 1.0; April 25, 2008) contains 20,027 bioactive peptides derived from 19,438 
precursor proteins obtained from 2,820 metazoan species. The peptides and proteins in the 
PeptideDB were collected from BLAST alignments, annotations in the UniProt database, and 
published literature. The 19,208 out of 19,438 precursor proteins in the PeptideDB were classified 
into 373 peptide families based on sequence similarities and information available in the literature, 
while the remaining 230 precursor proteins with no significant homology were classified in a 
“unique peptide group”. The 48% (178) of protein families have known motifs in the Prosite 
(http://prosite.expasy.org), Pfam (http://pfam.sanger.ac.uk), SMART (http://smart.embl-
heidelberg.de), and peptidemotifdat
31
 databases. The peptide and precursor protein length 
distribution indicated that 97% peptides and 98% precursor proteins are less than 200 and 500 
amino acids in length, respectively. The PeptideDB database is searchable using the PeptideDB 
accession number, peptide name, peptide length, monoisotopic mass, amino acid sequence, 
organism common name, peptide family, or UniProt accession number.  
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PEPSHOP 
PepShop (http://stagbeetle.animal.uiuc.edu/pepshop.html) is a comprehensive web resource 
that enables the identification and discovery of neuropeptides.
32
 PepShop integrates public 
databases encompassing sequence, annotation, and tandem mass spectra (MS/MS) information 
with bioinformatics and proteomics tools to input, search, align, predict, and identify prohormone 
and peptides. PepShop integrates experimentally confirmed prohormone and peptide information 
from the SwePep, UniProt, and NeuroPred repositories. The PepShop data warehouse can be 
searched by species (seven species), prohormone identifier (668 unique sequences), exact amino 
acid sequence, and peptide monoisotopic mass with adjustable mass tolerance level. The 
neuropeptides in the PepShop database are linked to the spectral library of SwePep. PepShop 
enables the search of user-provided MS/MS profiles against the in-house neuropeptide repository 
using three open source database search programs, Crux, X! Tandem, and OMSSA. In PepShop, 
identified peptides are automatically linked to prohormone and peptide information.  
NEUROPEPTIDES.NL 
Neuropeptides.nl (http://www.neuropeptides.nl) database contains information about the 
known neuropeptides, neuropeptide genes, precursor proteins, and their expression in the mouse 
brain.
33
 The neuropeptide genes have been grouped into families based on structural or functional 
similarities among them. The neuropeptide genes are linked to their corresponding locus on the 
human genome through UCSC (University of California Santa Cruz; http://genome.ucsc.edu) 
human genome browser. The UCSC browser provides further information about the gene location, 
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transcripts, and base wise conservation in other species. The precursor proteins are linked to their 
isoforms and homologous proteins in related species using pre-computed BLAST results. 
Comparisons of precursor proteins across species indicate that precursor proteins are less 
conserved relative to the neuropeptides and their processing sites. Furthermore, the neuropeptide 
genes are linked to the mouse expression data for the annotated genes in the online Allen Brain 
Atlas or GenePaint.org resources.  
EROP-MOSCOW 
EROP-Moscow (http://erop.inbi.ras.ru) database provides comprehensive information 
about 10,575 naturally occurring bioactive oligopeptides.
34
 These peptides ranged from 2 to 50 
amino acids in length. Of 10,575 bioactive peptides in the current version of the database, 2,362 
peptides are neuropeptides. The database provides information about each neuropeptide including 
peptide length, sequence, precursor protein, PTMs, biological functions, molecular mass, 
isoelectric point, and literature sources. The majority of the information about neuropeptides and 
other functional classes of bioactive peptides (such as toxins, antimicrobial) was extracted from the 
scientific literature. The peptides are also linked to the external generalized databases, Swiss-Prot, 
protein identification resource (PIR), and PubMed. Based on sequence similarity peptides are also 
grouped into homologous families.  
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NCBI REFSEQ 
The National Center for Biotechnology Information (NCBI) Reference Sequence 
(http://www.ncbi.nlm.nih.gov/RefSeq/) is a collection of genomic, transcripts and protein 
sequences. The database contains more than 13 x 10
6 
protein entries from more than 16,000 
species.
35
 RefSeq contains well annotated sequences for the neuropeptide genes and precursor 
proteins. The key features of the RefSeq are less redundancy in records and improved cross-
referencing between nucleic acid and protein information. The RefSeq records are generated either 
using annotation pipelines or through manual annotation. The accession numbers of the protein 
records derived from the annotation pipelines and manual annotation are denoted with prefixes 
“XP_” and “NP_”, respectively. 
1.4 PEPTIDE IDENTIFICATION BY TANDEM MASS SPECTROMETRY 
Several computational approaches and software tools are available to identify peptide 
sequences from tandem spectra. These approaches are grouped into four categories depending 
upon how peptide sequence is assigned to the tandem mass spectra: (1) de novo peptide 
identification, (2) sequence database searching, (3) spectral library searching, and (4) hybrid 
approach. 
The de novo approach extracts peptide sequences from the experimental spectra without 
any prior knowledge about the peptide sequences.
36
 This approach is based on the rationale that the 
two fragment ion peaks in the tandem spectra differ by a single amino acid and sequence of the 
peptide can be obtained by calculating the mass differences between the adjacent peaks.
37
 Novel 
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peptides can be identified by this approach but at the same time the error rate is high due to 
incomplete fragmentation patterns in tandem mass spectra.
36, 38
 
The database search approach identifies spectra by comparing experimental spectra against 
theoretical spectra generated from peptides in the sequence database. This approach is useful when 
the peptide sequence is known and present in the sequence database or when the experimental 
spectra have low quality and incomplete fragmentation. The sequence database approach can 
match tandem mass spectra containing sufficient information (i.e., signal peaks) to peptide 
sequences in the database even if the spectra are of poor quality (too many non-signal peaks or low 
intensity of signal peaks) and contains incomplete fragmentation.
37
 However, confidence in peptide 
identification is decreased if the spectrum quality is too low
39
 or when many fragment ions are 
missing.
16
 The database search approach cannot identify those peptides that are not present in 
searched database.
22
 
The spectral library approach identifies peptides by searching the experimental spectrum 
against already annotated spectra present in the spectral library.
22, 40, 41
 The spectral library search 
approach is based on the rationale that MS-based peptidomics experiments include many peptide 
spectra already annotated in prior studies.
42
 Like the sequence database search approach, this 
approach cannot identify novel peptides. 
The hybrid approach is a combination of de novo and sequence database search approach. 
In the first step, short sequence tags (i.e., short sequences of 3-5 amino acids in length) are 
extracted from the tandem mass spectra using de novo approach and then these sequence tags are 
searched against the sequence databases using database search methods. This approach is designed 
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to overcome the limitations of de novo approach (failure to correctly match spectra with 
incomplete information and poor quality) and the database search approach (identification of novel 
or mutated peptides).
22, 41
 The database search programs were used in the current studies and will 
be discussed in detail. 
1.5 OVERVIEW OF THE DATABASE SEARCH APPROACH 
The database search approach is the most common approach to detect peptides in the 
bottom up proteomics studies primarily due to the ability to handle spectra with incomplete 
fragmentations and of low quality (low intensity of the signal peaks or presence of many non-
signal peaks). Figure 1.4 shows an overview of the database search approach. The database search 
programs correlate experimental spectra with the in silico theoretical spectra generated from the 
peptide sequences in the database.
40
 One or more scores or indicators are reported with each score 
indicating the strength of the peptide-spectrum match. Furthermore, in addition to existing 
proteomic databases, this approach can use information from translated genomic databases.
22, 41
 
Many database search programs have been developed and routinely used for the peptide 
identification including OMSSA,
43
 Crux,
44
 X! Tandem,
45
 Mascot,
46
 SEQUEST,
47
 and Tide.
48
 
These programs differ in the heuristic search algorithms and the way the experimental-theoretical 
spectra matching score is computed.  
The database search programs match individual spectrum against a subset of all the 
peptides present in the sequence database that fall within the mass range (tolerance) of the 
precursor peptide. The scores are converted to either p-values or E-values that reflect the statistical 
significance of the match based on a theoretical test distribution or an empirical test distribution 
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based on other peptide spectrum matches.
41
 The p-value is the probability of obtaining the match 
between experiment and theoretical spectra due to chance. The E-value is closely related to p-value 
but denotes the expected number of random database matches that received score as high as the 
current match.  
SEARCH PARAMETERS FOR THE DATABASE SEARCH PROGRAMS 
The parameter specification of the database search program affects peptide identification. 
The parameters influence the selection of the candidate peptides that have similar mass as the 
experimental spectrum, peptide identification accuracy, and speed of search.
22, 49
 There is no best 
set of parameter values and the optimal search parameter values depends on multiple factors 
including tandem MS datasets, search methods and tools, and analysis strategies.
49
 The most 
widely used search parameters are: monoisotopic or average isotopic mass, precursor and fragment 
ion tolerance, enzyme specificity, PTMs, and type of fragment ions. 
Monoisotopic or Average mass 
All database search programs allow the specification of the method to calculate the peptide 
masses from the m/z values of the peptide ions. The calculated masses from the m/z values can be 
closer to the monoisotopic mass (with 
12
C atoms only) or average mass (including 
13
C atoms). The 
monoisotopic mass is the mass of the most common isotopic form of the amino acids, while the 
average mass represents the weighted average of all the isotopic forms of the amino acids. The 
monoisotopic and average isotopic masses are usually used for the high-resolution and low-
resolution mass spectrometers, respectively.
22
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Precursor and fragment ion tolerance 
After calculation of the peptide mass from the m/z value of the precursor ion from the 
experimental spectrum, the database search program selects the database peptide sequences 
(candidate peptides) that fall within a certain mass range (precursor ions tolerance) of the 
experimental spectrum. The choice of the precursor mass tolerance value depends on the accuracy 
of the mass spectrometers that range from 0.05 Da for the high mass accuracy instruments such as 
Fourier transform to 3 Da for the low mass accuracy instruments such as ion traps.
22
 The higher 
value of the precursor ion tolerance can affect the speed of searches and accuracy of peptide 
identification due to large number of available candidate peptides.
41
 However, studies have shown 
that selection of few candidate peptides can also hamper the performance of the database search 
programs.
50
 This is because many database search programs use the score distribution of the 
candidate peptides to assign significance values to the correct peptide match. The lack of sufficient 
candidate peptides can lead to potential incorrect matches. In addition to the precursor ion 
tolerance, the fragment ion tolerance can also be provided for the database search programs.  
Enzyme specificity 
The choice of the digestion enzyme to process the protein sequences into peptides depends 
on the experimental settings. Accurate specification of the digestion rules can reduce the search 
space to only those candidate peptides that satisfy the digestion rules of interest. Most database 
search programs are designed for tryptic peptides; however these programs can also be used for the 
neuropeptide searches by specifying custom cleavage rules. For neuropeptide searches, the protein 
library can be processed with a nonspecific enzyme that cleaves on every peptide bond while 
allowing for the large number of missed cleavages.
26
 An alternative strategy is to instruct the 
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database search program to use the peptide sequence database without further processing.
16
 
NeuroPred and similar tools can be used to create such peptide databases. 
Post-translational modifications (PTMs) 
PTMs are the covalent modifications in the proteins that occur either due to proteolytic 
cleavage or addition of modifying groups.
51
 So far, approximately 200 different types of PTMs 
have been reported.
52
 Each modification makes the mass of the precursor and fragment ions 
different from the masses of peptides in the sequence databases. The database search programs 
select candidate peptides from the sequence database on the basis of observed mass and failure to 
incorporate these PTMs would lead selection of incorrect candidate peptides.
53
 Most database 
search programs allow the specification of three different types of PTMs: (1) the modification of 
specific residue when present at peptide terminus such as pyro-glutamination of glutamine and 
glutamic acid residues; (2) modifications of any residue present at peptide terminus such as N-
terminal acetylation and C-terminal amidation; and (3) modification of particular residues 
regardless of their position in the sequence such as phosphorylation of serine, threonine, and 
tyrosine.
46
 The PTMs can be applied either in fixed fashion (all occurrences of the residue are 
modified e.g., addition of 57 Da on every occurrence of cysteine due to cysteine alkylation) or in 
variable fashion (residue is only conditionally modified). The variable modification increases the 
search space exponentially with increase in the number of PTM specified, which can lead to 
reduction in search speed and peptide identifications.
20
 Common PTMs for the neuropeptides are 
glycosylation, amidation, acetylation, phosphorylation, and sulfation. These PTMs occur in 
secretory granules and are species- or tissue-specific.
4
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Types of fragment ions 
The value of this parameter depends on the type of fragmentation method used in the mass 
spectrometry.
22
 The ions are named based upon the type of bonds that are broken between the two 
adjacent amino acids during the fragmentation process. The most common fragmentation is the 
CID which produces b- and y-ions due to the breakage of amide bonds. The breakage of bond 
between the alpha carbon and carbonyl carbon yields a- and x-series ions. Furthermore, the 
methods such as ETD mainly results in c- and z-ions due to the fragmentation of bonds between 
the amide nitrogen and alpha carbon. The fragment ions are classified as N-terminal or C-terminal 
if the charge is retained on the N-terminus or C-terminus of the peptide, respectively. The N-
terminal ions include a-, b-, and c-ions, while x-, y-, and z-ions are classified as C-terminal ions.
54, 
55
 The database search program predicts the fragment ions for the selected candidate peptides 
according to this search parameter and then compares them with the fragment ions present in the 
experimental spectrum.
49
  
1.6 REVIEW OF SELECTED DATABASE SEARCH PROGRAMS 
Many database search programs are available including OMSSA, Crux, Mascot, Sequest, 
Tide, Myrimatch, and X! Tandem. A brief description of the selected database search programs, 
their scoring schemes and conversion of scores to either E- or p-value is given below. The X! 
Tandem and OMSSA use a parametric approach (fitting parametric distributions without using 
decoy peptides) to obtain significance values, while Crux uses a semi-supervised parametric 
approach (fitting parametric distributions from the scores of decoy peptides) to compute the p-
value. 
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X! Tandem 
X! Tandem (http://www.thegpm.org/tandem) is an open source program written in the C++ 
programming language and can be executed in multiple platforms (Windows, Linux, OS X).
45
 X! 
Tandem assigns peptide sequences to provided tandem spectra in the multistep process. First, X! 
Tandem preprocesses the input tandem spectra to remove noise and artifacts (i.e., peaks resulting 
from the ions other than the selected ions in MS) using information provided in the search 
parameter file. The X! Tandem selects the 50 (user adjustable) most intense fragment ion peaks 
and the intensity values of the selected peaks are normalized using a user-adjustable dynamic range 
value (a parameter showing the difference between the most intense and least intense fragment 
peak in the spectra; the default value is 100). In the normalization step, the intensity of the most 
intense peak is set to one-hundred, while the intensities of the remaining peaks are linearly scaled 
with respect to most intense peak. Furthermore, peaks with scaled intensity below one are removed 
from the normalized spectrum. Second, X! Tandem processes the database protein sequences into 
peptides using specified enzymatic cleavage rules and the resulting peptide sequences are further 
subjected to chemical and PTMs. Third, the normalized observed spectrum is correlated to the 
theoretical spectra generated from the peptide sequences from the target search database. This step 
assigns scores to each peptide-spectrum match indicating the strength of the match.
45
 Fourth, X! 
Tandem creates an XML output file containing details of the match such as precursor ion mass, 
charge state, hyperscore, E-value, peptide sequence, protein sequence, search parameters and 
others (http://www.thegpm.org/ docs/X_series_output_form.pdf).  
X! Tandem first computes a convolution score (preliminary) for each peptide-spectrum 
match. The convolution score is the dot product of the intensities of the matched fragment ions 
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between experimental and theoretical spectra. The dot product is used because only the matched 
ions are considered. The convolution score is converted into a hyperscore by multiplying the score 
by the factorial number of matching b- and y-ions (the usage of b- and y-ions corresponds to the 
CID spectra). The default use of the factorial of the number of matched b- and y-ions can be 
modified to include other ions such as a-, c-, x- and z-ions in the scoring. The use of factorial is 
based on the hypergeometric distribution. The hyperscore is calculated as: 
                    ∑   
 
 
   
The database search produces a hyperscore distribution of all the peptide-spectrum 
matches, which is assumed to follow a hypergeometric distribution. The hypergeometric 
distribution is a parametric discrete probability distribution that allows extrapolation. The 
hyperscores are log-transformed and the hyperscores higher than the intersection between the log-
transformed hyperscores (on the x-axis) and log transformation of the frequency of the hyperscores 
(i.e., E-value on the y-axis) are assumed to be significant.
39
 
OMSSA 
Open Mass Spectrometry Search Algorithm (OMSSA; http://pubchem.ncbi.nlm.nih.gov/ 
omssa) is an open source program written in the C++ programming language that can be compiled 
across multiple platforms including Windows, Linux, Solaris, and OS X.
43
 OMSSA uses a multi-
step strategy to identify peptides from the spectra.  
In the first step, OMSSA determines the precursor charge state of the spectrum by counting 
the number of peaks that fall below the m/z value of the precursor ion. A spectrum with more than 
95% peaks below precursor m/z is considered in +1 precursor charge state, while the spectrum is 
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searched with +2 and +3 precursor charge states if less than 95% peaks fall below precursor m/z 
values. The accurate determination of the charge state is important in OMSSA because candidate 
peptides (peptides within the precursor mass tolerance) for each spectrum are selected using the 
neutral mass (i.e., sum of the masses of amino acid residues in a peptide and mass of the hydroxyl 
group) of the precursors. The second step involves preprocessing of experimental spectra to 
remove noise peaks including peaks with intensity below 2.5% of the highest peak in spectrum, 
precursor ion peaks, peaks that are within 2 Da of m/z distance from the examined peaks, and 
peaks that can be explained by neutral mass losses (loss 17 Da for ammonia, and 18 Da for water). 
Furthermore, peaks are examined in the order of intensity, for the precursor charge states +1 and 
+2 only the most intense peak within ±27 Da of the peak being examined is selected, while for the 
+3 charge state the two most intense peaks are selected within ±14 Da of the peak being examined. 
Third, candidate peptides from the sequence database that fall within precursor mass tolerance of 
the spectra are selected. The candidate peptides masses are calculated considering the specified 
PTMs. Fourth, to improve the speed of searches, the m/z values from the experimental spectra are 
converted to integer values using 100 as the scaling factor (user-adjustable), the sequence library is 
mapped to memory, and the observed spectra are sorted, and indexed by the precursor mass. Fifth, 
+1 charge fragment ions are calculated for precursor charge states +1 and +2, while both +1 and +2 
fragment ions are calculated for precursor charge state +3 when the peak is above m/2 and below 
m/2, respectively, where m is the precursor mass. Sixth, the fragment ion peaks in the experimental 
and theoretical spectra are compared and a score is calculated. Only the theoretical spectra that 
have at least one fragment ion match with any of the top three (user-adjustable) most intense peaks 
in the experimental spectrum are scored to improve the sensitivity of the algorithm.
43
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The scoring of the experimental-theoretical spectra matches is based on the assumption that 
the distribution of the number of matched ions follows a Poisson distribution. Lambda (the Poisson 
mean parameter) is calculated by considering the fragment ion tolerance, number of peaks in the 
experimental and theoretical spectra, and the mass of the precursor. The lambda is calculated by 
counting the number of spectrum peaks that fall within two matched fragment ions from any one 
fragment ion series (e.g., b- or y-ions). The count is adjusted by dividing with the mass of the 
precursor. Lambda is the sum of the adjusted counts. The calculation of the lambda parameter is 
different for the spectra with +1 charge fragment ions than spectra with both +1 and +2 fragment 
ions. During the preprocessing step, the OMSSA noise filter removes some but not all noise peaks 
(peaks not representing fragment ion peaks are known as noise peaks) from the experimental 
spectra leading to inclusion of noise peaks in the calculation of the Poisson mean. The probability 
of the match with a given number of fragment ion matches (x) and lambda can be calculated as 
follow: 
        
  
  
    
The OMSSA report results according to E-value which is the expected number of random 
database matches with probability equal or more significant than the one observed due to chance. 
OMSSA calculates this E-value by multiplying the number of candidate peptides (i.e., database 
peptides within precursor tolerance of observed spectra) with Poisson probability of the match. 
             ∑        
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Crux 
Crux is an open source reimplementation of Sequest, the first commercial database search 
program.
44
 Like in the previous database search programs, the first step in Crux is the identification 
of all database candidate peptides that are within the precursor mass tolerance range of the 
experimental spectra. The candidate peptides are selected either by querying spectrum masses 
against the entire sequence database or against an indexed database of predicted peptides. This 
indexed database is a preprocessed binary sequence database obtained from the in silico digestion 
of precursor sequences in the target database and followed by sorting of the resultant in silico 
generated peptides by their masses. The index database allows efficient retrieval of candidate 
peptides upon query allowing Crux to perform faster searches than the original Sequest program. 
The candidate peptides are matched with the experimental spectrum and indicators of the strength 
of the experimental and theoretical spectra matches are reported. These indicators are: cross-
correlation score (XCorr), delta Cn (ΔCn), Sequest preliminary score (Sp), and p-value.  
First, Crux processes the spectra by taking the square root of each intensity peak value, 
normalizes the peak intensities to sum to one hundred, and round each m/z to the nearest integer 
value. Second, Crux uses the 200 most intense peaks to compute a Sp score. The higher the value 
of Sp score denotes higher similarity between theoretical and experimental spectra. The Sequest 
version used Sp score to filter top 500 database candidate peptides that are subsequently scored and 
reranked using XCorr to increase the speed of searches. The default version of Crux “search-for-
matches” does not calculate Sp score. In this study, the Crux parameter file was modified to 
retrieve this score. 
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The experimental spectrum is preprocessed prior to calculating XCorr scores, the primary 
score of Crux that indicates the similarity between experimental and theoretical spectra. First, 
spectra are processed by taking the square root of each intensity peak value and rounding each m/z 
to the nearest integer value. The processed spectrum is divided into ten bins and the peaks intensity 
in each bin is set to a maximum of 50. A theoretical spectrum is synthesized for each candidate 
peptide containing b- and y-ions with peak intensity of 50, ±1 m/z peaks with intensities of 25, and 
with peak intensity 10 for b- and y-ion peaks with neutral mass loss of ammonia and b-ion peaks 
with neutral loss of water. The two spectra are correlated and higher XCorr denotes higher 
similarity between experimental and theoretical spectra. Crux computes a relative score (ΔCn) 
from the XCorr scores denoting the relative ranking of each peptide match in terms of other 
peptide matches for any particular spectrum. The deltaCn reflects the difference in the XCorr score 
of the top peptide-spectrum match relative to other matches for that spectrum. The deltaCn score 
indicates the strength of the top match relative to the second best match. 
 Crux calculates a p-value from a Weibull distribution obtained by using XCorr scores from 
all peptide-spectrum matches.
56
 The p-value is the probability that the match between the 
experimental and target peptide spectrum is due to chance. Crux reports spectrum specific 
Bonferroni-adjusted p-values, adjusted by the number of candidate peptides. Crux uses 40 Weibull 
points (the minimum numbers of XCorr scores required to estimate the p-value) to estimate p-
values. However, prior studies have shown that increase in the number of Weibull points increase 
significance levels of the estimated p-values.
16
 Crux generates in silico peptides (decoy peptides 
described in the next section) when the number of candidate peptides are less than the number of 
Weibull points required to estimate p-values using Weibull distribution. The decoy peptides are 
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generated by keeping the terminal amino acids of the candidate peptides fixed while shuffling the 
internal amino acids of the peptide. The Crux sampling with replacement procedure is repeated 
until a minimum number of Weibull points are obtained.  The source code of Crux was modified to 
obtain raw p-values for each spectrum using different values of Weibull points.  
1.7 FACTORS AFFECTING PEPTIDE IDENTIFICATION 
Accurate peptide identification from the tandem spectra remains challenging despite the 
many parametric, semi-parametric, and non-parametric methods available to calculate the 
significance levels of a match between the experimental and theoretical spectra. The significance 
levels provide an objective criterion to assess the likelihood that the scores of target peptides could 
be observed by chance. A large number of observed spectra are either missed due to significant 
levels that do not surpass the minimum user-defined threshold (false negative) or the match 
significance surpasses the minimum threshold yet the match is incorrect (false positive). Several 
factors influence the significance levels of the peptide-spectrum matches including: search space, 
peptide length, missing ions and low spectrum quality, and incomplete databases. 
IMPACT OF THE SEARCH SPACE DENSITY ON PEPTIDE IDENTIFICATION 
The precursor mass tolerance, choice of a digestion enzyme, and PTM searches influence 
the effective database size (the number of database peptides that have mass within the precursor 
tolerance of the experimental spectrum).
41, 49
 A spectrum with fewer database candidate peptides is 
more likely to produce a correct peptide match relative to a spectrum with more candidate peptides. 
The presence of large number of candidate peptides reduces the sensitivity of the database search 
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programs as more incorrect peptides have a chance to receive a score higher than the correct 
peptide matches leading to an increase in the false positive results. The higher number of incorrect 
peptides with score as extreme as the correct target peptide leads to lower significance values for 
the corresponding spectrum. On the other hand, many database search programs use all candidate 
peptides scores for a spectrum to fit a distribution and calculate significance values for the match.
49
 
For example, X! Tandem estimates E-value from the distribution of hyperscores from all peptide 
matches for a spectrum.
57
 Low number of candidate peptides increases the E-value and the match 
becomes less significant.
16
 A wider precursor tolerance can be used to generate enough number of 
candidate peptides to estimate significance values in the absence of sufficient candidate peptides.
49
 
An alternative approach is to generate decoy peptides when sufficient number of candidate 
peptides is not available to estimate significance.
56
  
IMPACT OF PEPTIDE LENGTH ON PEPTIDE IDENTIFICATION 
The ability of the database search programs to accurately identify peptides mainly depends 
on the availability of a sufficient number of matching fragment ions.
16
 Short peptides have a higher 
chance to be missed by the database search programs due to less significance values.
16, 20, 58
 The 
short peptide tends to receive a score that is not different from the other matches of the spectrum 
due to less number of possible fragment ions. This problem is further complicated by other factors 
such as missing ions and presence of fragment ions due fragmentation of more than one peptides in 
a single spectrum.
16
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IMPACT OF MISSING IONS AND LOW SPECTRUM QUALITY ON PEPTIDE IDENTIFICATION 
The incomplete fragmentation and noise (non-signal spectra peaks) in the spectra reduces 
the number of correct peptide identifications due to lower significant p- or E-value levels assigned 
by the database search programs. The increase (becoming less significant) in p- or E-values with 
both factors is due to the lower score of the correct matches that is not significantly different from 
the other matches of the spectrum. Most database search programs use intensity to select signal 
peaks to be used in their scoring functions. The low intensity of signal peaks relative to the noise 
peaks reduces the contribution of signal peaks in the scoring functions which can lead to the lower 
scores for the correct peptide matches.
26
 In the case of same PTM occurring on more than one 
residue on a single peptide (e.g., phosphorylation of serine and threonine), the confidence in 
localization of the PTM is reduced in the absence of fragment ions representing the exact residue 
modified.
49
 
FACTORS IMPACTING SEQUENCE DATABASES 
The database search programs can fail to identify a peptide match if the corresponding 
peptide sequence is absent from the target database. This could be either due to the: (a) presence of 
a closely related variant of the peptide or protein rather than exact sequence in the database; (b) 
sequencing errors; (c) mutation in the sequence; (d) polymorphism; or (e) presence of homologous 
sequence in the database from closely related species.
59
  
In the context of the standard database search approach (searching database with a narrow 
precursor mass tolerance) a peptide sequence is considered missing when either a peptide sequence 
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is totally absent from the sequence database or a closely related variant of the sequence is present 
in the database. This is because it can change the peptide mass and the resulting MS/MS 
fragmentation patterns of the b- and y-ions making the observed-theoretical spectra unmatchable. 
The error tolerant searches are assumed to work better than the standard database searches in such 
cases.
59
 
Another reason could be the complex dissociation chemistry of peptides in MS that can 
permute or rearrange the sequence of peptides in sample. Studies have shown that the larger b-ions  
have higher tendency to form cyclic structures in which sequence ends are fused together followed 
by reopening of the ions at different residues instead of the original fused positions. Most database 
search programs do not take into account the possibility of peptide ion rearrangements while 
counting the number of shared peaks between the observed and theoretical spectra.
60
 The exclusion 
of such permuted ions from scoring can contribute towards lower scores for the peptide matches.       
MULTIPLE HYPOTHESIS TESTING 
Typical MS-based peptidomics or proteomics experiments involve the analysis of 
thousands of experimental tandem spectra leading to a multiple hypothesis testing scenario.
61
 Two 
different types of measures have been proposed to control multiple hypothesis testing problems: 
family wise error rate (FWER) and false discovery rate (FDR). The first measure is FWER the 
probability of rejecting at least one true null hypothesis among all m independent hypotheses. 
Given m independent hypothesis and the probability of error for each test (α), the FWER is 
calculated as: 
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The quantity (1- α) represents the probability of no error and (1- α)m represents the 
probability of no error in the m independent tests.
62
 For example for m = 100 and α = 0.05 then 
FWER is 0.99 (or 99% chance of observing at least one falsely rejected null hypothesis). Many 
methods have been proposed to control such high FWER and these methods are divided into 
categories: (a) single step approach, in which all p-values are adjusted equally; and (b) sequential 
step approach, in which each p-value is adjusted separately.  
The Bonferroni adjustment is a single step approach that is used in the current study. This 
adjustment can be applied in two ways: (1) by multiplying the probability of type I error (alpha 
level) by the number of tests (adjusted alpha level) and accepting or rejecting the null hypothesis 
by comparing significance values against adjusted alpha level; and (2) by adjusting the raw 
significance values by multiplying them by the number of hypothesis tests and then comparing the 
adjusted significance values against the alpha level to accept or reject the null hypothesis. The 
Bonferroni adjustment is a highly conservative approach.  
An alternative approach to control FWER is the Holm’s sequential step wise adjustment 
method.
63
 In this method the unadjusted p-values are arranged in an ascending order (from the 
smallest to the largest) and each unadjusted p-value is adjusted by multiplying with m-j+1, where 
m refers to the total number of tested hypotheses and j is the rank of the unadjusted p-value in the 
ordered list. The Holms method is less conservative than the Bonferroni method and the hypothesis 
rejected by the Bonferroni method would also be rejected in the Holm’s step down procedure. 
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 Benjamini and Hochberg proposed a false discovery rate (FDR) method as a second 
measure to handle multiple testing problems.
64
 This method allows a certain percentage of false 
positive hypotheses among all rejected hypothesis. The FDR is defined as the expected fraction of 
false positive identifications or hypothesis among all rejected hypotheses. The FDR is calculated at 
certain threshold (α) by dividing the number of false positives (FP) with the total number of 
rejected hypothesis i.e., true positives (TP) and false positives (FP). Thus, peptide-spectrum 
matches need to reach statistical significance values that surpass the stringent threshold that 
controls for multiple hypothesis testing. 
1.8 FDR VIA TARGET-DECOY APPROACH 
In the MS/MS-based peptidomics studies, the FDR can also be calculated using the target-
decoy database search strategy
41, 65-68
 or mixture model approach. The target-decoy approach 
(TDA) is the simplest and most popular approach to estimate error rate. This approach is easily 
applicable to several experimental setups and demonstrates the ability of the scoring functions to 
distinguish between correct and incorrect peptide-spectra identifications. The TDA is based on the 
assumption that the score distribution of incorrect matches from the target database is identical to 
the score distribution of the decoy matches.   
The accuracy of the TDA based FDR estimates depend on the way the target decoy search 
strategy is conducted. First, the decoy sequences can be generated either through sequence 
reversal, shuffling, or randomization. Details on the decoy construction methods are given in the 
next section. However, various studies have reported that the type of the decoys have little to no 
effect on the FDR estimates. Second, the tandem spectra can be searched against the combined 
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target-decoy database (concatenated database) or target database can be searched separately from 
the decoy database to obtain correct and random score distributions. The concatenated target-decoy 
database searches are preferred over separate target and decoy database searches because separate 
searches can produce conservative estimates. This is because in the absence of competition 
between target and decoy peptides for the same spectra the decoy peptides can receive higher 
scores relative to the concatenated search strategy.
41, 65, 68
 Third, the choice of the formula to 
compute FDR can produce conservative estimates. The (2 * Ndecoys / (Ndecoys+ Ntargets)) provides 
conservative FDR estimates relative to the Ndecoys/Ntargets formula.  
1.9 GENERATION OF DECOY PEPTIDES 
A decoy peptide is an in silico generated amino acid sequence that is not present in the 
original target database (database containing correct peptides for tandem spectra). The database 
search methods can use a database of decoy peptides to compute the statistical significance value 
of the peptide-spectrum matches
44
 or to determine the score thresholds that separates incorrect 
from the correct peptide identification and estimation of the corresponding FDR
41
. The FDR 
estimates and significance values can be estimated from the decoy database based on the 
assumption that the probability of the incorrect match in the target database can be estimated from 
the peptide-spectrum matches in the decoy database.
40, 41, 65, 69
 Several methods are used to generate 
the decoy peptides including the sequence reversal method, sequence shuffling method, and 
random sequence generation method. Each method has its own advantages and disadvantages. A 
brief description of these methods follows. 
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The sequence reversal method generates decoy peptides from the original target peptide by 
sequence reversal (change in the amino-carboxyl orientation) of the target peptide. This method 
generates the decoy peptides with the same amino acid composition, length and mass distributions 
as the target peptides. However, the generated peptides are not truly random (i.e., the peptides are 
generated by reversing the target peptides) and the method cannot be used for palindromic 
sequences.
68
 The sequence reversal method is used in X! Tandem.
45
 
The sequence shuffling method generates decoy peptides by randomly shuffling the amino 
acids in the target peptides. This method preserves the amino acid composition, length and mass 
distributions of the target peptide. The sequence shuffling method allows repeating the analysis 
many times by creating different versions of the target peptides than sequence reversal method.
68
 
This method is implemented in the Crux program to estimate p-values.
56
  
The random sequence generation method generates decoy peptides by randomly selecting 
amino acids according to the amino acid frequency and peptide length distributions in the target 
database. This is undesirable because simple random method cannot preserve amino acid 
homologies of the target database in the corresponding decoy databases. A better model for the 
generation of random peptides consists in using a Markov chain model parameterized with the 
amino acid frequencies of the target database. This approach generates similar amino acid patterns 
to the target peptides such as acidic or basic regions. The random generation method is 
implemented in Mascot.
68
 The random generating methods can generate many more decoy 
peptides than the target peptides and this can be undesirable for generating false positive estimation 
as the relative proportion of decoy to peptide peptides can add decoy bias. Alternatively, the large 
number of decoy peptides can be used to estimate the significance values for the peptide-spectrum 
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matches. Prior studies have shown that choice of the type of decoy database have low impact on 
the accuracy of FDR estimates.
65
 
The significance values for the database search programs can be computed either using the 
parametric approach, semi-parametric approach, or non-parametric approach. The parametric 
approaches assumes that scores of peptide-spectrum matches follow a certain distribution and the 
required distribution parameters are obtained from all the matches of particular a spectrum in the 
sequence database. For example, X! Tandem and OMSSA use the hypergeometric and Poisson 
distributions to calculate the E-values.
43, 45
 A semi-supervised parametric procedure uses decoy 
peptide-spectrum scores to fit a parametric distribution. An example is Crux that calculates p-
values by fitting Weibull distribution from the target and decoy XCorr scores.
56
 The significance 
values can be calculated using scores of decoy peptides in a non-parametric fashion (without 
assuming any distribution).
70
  
1.10 PERMUTATION TEST 
The strengths and limitations of the standard database search programs to identify peptide 
have been discussed in various comparative studies.
16, 20, 66
 The ability of the database search 
programs to discriminate between the correct and incorrect peptides identifications with good 
statistical significance values remains an open question. The database search programs must 
calculate significance of matches irrespective of the peptide size, spectra quality issues such as 
incomplete fragmentation, low signal to noise ratios, and precursor charge states.16 The statistical 
significance values for the peptide identification can be calculated either using parametric, semi-
supervised parametric, or non-parametric approaches.  
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The permutation test or randomization test is a non-parametric statistical significance test to 
estimate the significance values without assuming any particular distribution for the given data.
71
 
This makes permutation test useful because in many cases the distribution of the test statistic is 
usually unknown.
72
 Permutation tests can be used for any test statistic or indicator regardless of the 
original distribution of the test statistic. This makes the permutation test an ideal choice to perform 
sufficiency analysis and determine the statistic or indicator providing more accurate acceptance or 
rejection of the null hypothesis. In order to get p-values, a null distribution of the test statistic of 
interest is fitted by calculating all possibilities of the data points through rearrangement (peptide 
sequences in this case). The p-value is calculated as the proportion of rearranged or random 
peptides receiving equal or better score than the original target peptide. The permutation tests can 
be categorized into two categories: exact permutation test and Monte Carlo permutation test.  
An exact permutation test for a peptide sequence of a given length (L) involves calculation 
of the test statistic on all possible peptide sequences by sampling amino acids with replacement 
from a list of 20 standard amino acids. In practice, the enumeration of all possible peptide 
sequences for the peptides greater than eight amino acids in length would produce a large number 
of possible permuted peptides. For example, there are (20)
10 
= 10,240,000,000,000 possible ways 
to generate peptides of ten amino acids in length. These peptides provide possible values of test 
statistic, the associated distribution and exact p-value. The exact test provides an exact p-value (the 
p-value observed from an actual experiment) by dividing the number of permutations with score 
t(r) equal or higher than the original peptides t(s) with total number of permutations (N). 
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 However, the computation of p-values using exact test through enumeration of all possible 
peptide sequences is not feasible computationally. The second category of permutation test termed 
as approximate permutation test or Monte Carlo permutation test or randomized permutation test, 
generates sampling distribution without exhaustively enumerating all possible values of the test 
statistic.
71, 73
 This procedure provides empirical p-values that approach there exact p-values as the 
number of sampled permutation increases. The significance levels of the computed p-values 
depend on the number of sampled permutations. For example, to get a p-value of 10
-6
 about 
>=1,000,000 permutation values must be generated. The p-values for the Monte Carlo permutation 
approach are computed in a manner similar to the exact permutation test. 
The permutation tests have been extensively used in many bioinformatics areas that include 
analysis of gene expression data, QTL detection, allelic association analysis, and modeling ChIP 
sequencing.
73
 Likewise, permutation tests can be applied for MS-based peptidomics studies as 
peptides and proteins are made up of finite (20 standard) number of amino acids. However, it is not 
practically feasible to enumerate all possible peptide sequences for peptides greater than eight 
amino acids in length, for example, there are (20)
10 
= 10,240,000,000,000 possible ways to 
generate different peptides of ten amino acids in length. Therefore, in this entire thesis we used the 
Monte Carlo permutation approach to convert scores produced by the database search programs 
into p-values. 
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1.11 FIGURES 
 
 
Figure 1.1. Classical and nonclassical neuropeptide processing scheme. First, the N-terminal 
sequence that drives translocation of the protein into the lumen of the endoplasmic reticulum is co-
translationally removed by a signal peptidase. Then, in the classical scheme, the prohormone is 
typically processed at sites containing Lys-Arg (KR), Arg-Arg (RR), or Arg-Xaa n -Arg, where n 
is 2, 4, or 6 (RxxR shown in figure). Processing at these basic amino acids involves endopeptidase 
action by an enzyme such as prohormone convertase 1 or 2 followed by the removal of the C-
terminal basic residue(s) primarily by carboxypeptidases E, although an additional enzyme 
(carboxypeptidase D) is also able to contribute to processing. An amidating enzyme that is broadly 
expressed in the neuroendocrine system converts C-terminal Gly residues into a C-terminal amide. 
In addition to this classical pathway, a large number of peptides have been found that result from 
cleavage at nonbasic residues. An example of this nonclassical pathway for the generation of a 
peptide previously found in brain is indicated; this fragment of chromogranin B involves cleavage 
between 2 adjacent Trp residues (WW). Many other nonbasic cleavage sites have been reported, 
including other hydrophobic residues, short chain aliphatic residues, and acidic residues. The 
enzymes responsible for the nonclassical pathway are not clear. Some of these nonclassical 
processing events may occur after secretion and be mediated by extracellular peptidases, although 
some of the nonbasic mediated cleavages appear to occur within the secretory pathway.
1
 
 
 
 
                                                 
1
 The AAPS Journal, 2, 2005, E449-E455, Neuropeptide-processing enzymes: Applications for drug 
discovery, Fricker L. D.; with kind permission from Springer. 
 39 
 
 
 
 
Figure 1.2. Tandem mass spectrometry (MS/MS). A sample is injected into the mass spectrometer, 
ionized and accelerated and then analyzed by mass spectrometry (MS1). Ions from the MS1 
spectra are then selectively fragmented and analyzed by mass spectrometry (MS2) to give the 
spectra for the ion fragments.While the diagram indicates separate mass analyzers (MS1 and MS2), 
some instruments can utilize a single mass analyzer for both rounds of MS.
2
 
 
 
 
 
 
 
 
 
 
 
                                                 
2
 http://www.piercenet.com/method/overview-mass-spectrometry 
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Figure 1.3. General view of the experimental steps and flow of the data in shotgun proteomics 
analysis. Sample proteins are first proteolytically cleaved into peptides. After separation using one- 
or multidimensional chromatography, peptides are ionized and selected ions are fragmented to 
produce signature tandem mass spectrometry (MS/MS) spectra. Peptides are identified from 
MS/MS spectra using automated database search programs. Peptide assignments are then 
statistically validated and incorrect identifications filtered out (peptide STHICR). Sequences of the 
identified peptides are used to infer which proteins are present in the original sample. Some 
peptides are present in more than one protein (peptide HYFEDR), which can complicate the 
protein inference process.
3
 
 
                                                 
3
 Springer and the Methods in Molecular Biology, 367, 2007, 87-119, Protein identification by tandem mass 
spectrometry and sequence database searching, Nesvizhskii A. I.; with kind permission from Springer. 
 41 
 
 
 
Figure 1.4. Tandem mass spectrometry (MS/MS) database searching. Acquired MS/MS spectra 
are correlated against theoretical spectra constructed for each database peptide that satisfies a 
certain set of database search parameters specified by the user. A scoring scheme is used to 
measure the degree of similarity between the spectra. Candidate peptides are ranked according to 
the computed score, and the highest scoring peptide sequence (best match) is selected for further 
analysis.
4
 
 
 
 
 
 
 
                                                 
4
 Nature Methods, 4, 2007, 787-797, Analysis and validation of proteomic data generated by tandem mass 
spectrometry, Nesvizhskii et al.; with kind permission from Nature Publishing Group. 
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 CHAPTER II: ACCURATE ASSIGNMENT OF SIGNIFICANCE TO 
NEUROPEPTIDE IDENTIFICATIONS USING MONTE CARLO K-PERMUTED 
DECOY DATABASES 
  
 43 
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2.2 ABSTRACT 
In support of accurate neuropeptide identification in mass spectrometry experiments, novel 
Monte Carlo permutation testing was used to compute significance values. Testing was based on k-
permuted decoy databases, where k denotes the number of permutations. These databases were 
integrated with a range of peptide identification indicators from three popular open-source database 
search software (OMSSA, Crux, and X! Tandem) to assess the statistical significance of 
neuropeptide spectra matches. Significance p-values were computed as the fraction of the 
sequences in the database with match indicator value better than or equal to the true target spectra. 
When applied to a test-bed of all known manually annotated mouse neuropeptides, permutation 
tests with k-permuted decoy databases identified up to 100% of the neuropeptides at p-value < 1 x 
10
-5
. The permutation test p-values using hyperscore (X! Tandem), E-value (OMSSA) and Sp 
score (Crux) match indicators outperformed all other match indicators. The robust performance to 
detect peptides of the intuitive indicator “number of matched ions between the experimental and 
theoretical spectra” highlights the importance of considering this indicator when the p-value was 
borderline significant. Our findings suggest permutation decoy databases of size 1 x 10
5
 are 
adequate to accurately detect neuropeptides and this can be exploited to increase the speed of the 
search. The straightforward Monte Carlo permutation testing (comparable to a zero order Markov 
model) can be easily combined with existing peptide identification software to enable accurate and 
effective neuropeptide detection. The source code is available at 
http://stagbeetle.animal.uiuc.edu/pepshop/MSMSpermutationtesting. 
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2.3 INTRODUCTION 
Neuropeptides participate in cell to cell communication and regulate many biological 
processes such as behavior, learning, and metabolism.
1
 Mass spectrometry has revolutionized 
neuropeptide characterization and quantification.
74-79
 However, detection is complicated by the 
neuropeptide size (typically 3 to 40 amino acids long) and by the complex post-translational 
processing that includes cleavage, and amino acid modifications of prohormones into 
neuropeptides.
1, 6
 
Database search programs are commonly used to identify peptides from tandem mass 
spectrometry experiments.
41
 These programs generate in silico theoretical spectra from target 
databases of known peptide sequences that have masses within a range (tolerance) of the observed 
peptide mass. The in silico spectra are then compared to the observed experimental spectra and 
indicator scores that signify the closeness of the match are computed. To assess the statistical 
significance of these matches, the observed-target match indicator is compared to the distribution 
of indicator values under the null hypothesis of no match using various methods. In the popular 
target-decoy approach, the experimental spectra are compared to spectra from a decoy database 
consisting of peptides sequences that were generated by reverting or reshuffling the amino acids in 
the sequences of the target database.
16, 41, 46
  
For neuropeptide identification, the target-decoy approach can result in false negatives 
because the small size of many neuropeptides leads to low observed-target match indicator values 
and consequently low significance levels.
16
 Furthermore, the small size of many neuropeptide 
leads to few decoy reshuffled sequences and the resulting granularity of the null distribution of 
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decoy scores further lowers the significance levels.
16, 20, 58, 80, 81
 At the protein level, alternative 
identification approaches have attempted to address the challenge of assessing statistical 
significance.
82, 83
 However, the implementations of the previous approaches do not work with 
widely used database search programs, do not use all the information resulting from the mass 
spectrometry experiment, and are biased by peptide length or assume one-direction progressive 
processing. Approaches that rely on fewer limiting assumptions and that use all the information 
available need to be evaluated. 
Permutation tests are well-suited for neuropeptide database searches by helping to 
overcome the finite combination of amino acids from small neuropeptides and do not rely on 
directional assumptions. Furthermore, permutation testing provides strong control of Type I errors 
thus minimizing the incidence of false positive results.
84
 Under the null hypothesis of no match, the 
experimental spectrum of a peptide is the result of a random sequence of amino acids provided that 
the total mass is close to the experimental mass. This requirement stems from the database search 
program strategy that only accepts sequences within a user determined range of the experimental 
spectra. The permutation statistical significance under the null hypothesis is then generated by 
using a decoy database of considering all possible amino acid sequences within the predetermined 
range of the experimental spectra. Under the null hypothesis any amino acid can be present at any 
position of the sequence, thus, addressing the exchangeable assumption required by the 
permutation test.
84
  
Monte Carlo sampling is used to reduce the number of possible sequences while providing 
an unbiased estimate of the p-value. Furthermore, the loss in statistical efficiency when estimating 
the p-value decreases with increasing number of random samples.
84
 The main advantage of the 
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Monte Carlo permutation approach proposed over existing decoy generation based on sequence 
reversion or reshuffling of the target sequence is the improved definition of the null distribution. 
The larger number of decoy sequences results in lower granularity and, thus, more precise 
assessment of the statistical significance of the observed matches. Two major advantages of the 
Monte Carlo permutation approach proposed over existing dynamic programming approaches
82, 83
 
is the simplicity of integration to existing database search programs, the use of all spectra 
information available and consideration of all possible spectra matching processes. 
This study demonstrates the use Monte Carlo permutation testing to overcome the 
limitations of current protein identification approaches to accurately assess neuropeptide statistical 
significance. This approach combines and extends the model-free property of current decoy 
databases with the more extensive search of dynamic programming approaches. The aims are: (1) 
to develop permutation resampling methodology that can be easily integrated with existing peptide 
database search software, and (2) to demonstrate the advantages of this approach to provide 
accurate measures of neuropeptide match significance using ideal and real experimental 
neuropeptide spectra. Supporting objectives were: (1) to develop and implement complementary 
novel permuted databases; (2) to determine the number of permutations required for accurate 
significance levels; and (3) to identify the neuropeptide match indicators within and across 
programs that are better suited to provide accurate statistical significance. 
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2.4 MATERIALS AND METHODS 
TANDEM SPECTRAL DATASET AND TARGET DATABASE 
Tandem mass spectra from a comprehensive list of 103 experimentally-obtained and 
manually annotated mouse neuropeptides were obtained from the SwePep database 
(http://www.swepep.org). These spectra were obtained using linear ion trap mass spectrometer 
coupled with liquid chromatography and electrospray ionization source.
25
 Neuropeptides were 
manually validated after identification using the X! Tandem database search program.
45
 The 
independent manual annotation step also ensured that the subsequent software comparison would 
not be biased in favor of the X! Tandem database search program. Of these, 80 neuropeptides were 
unmodified and the remaining 23 encompassed post-translational modifications (PTMs) including 
C-terminal amidation, N-terminal acetylation, phosphorylation, pyro-glutamination and oxidation. 
The spectra corresponded to 5, 68, 25, and 5 peptides that had precursor charge states +1, +2, +3 
and +4, respectively, and all charge states were observed in modified and unmodified peptides.  
Ideal uniform spectra of all possible b- and y-ions with +1 product charge state were 
simulated for 103 annotated experimental spectra. The ideal spectra also included all the PTMs 
identified in the corresponding experimental spectra. The neutral mass loss peaks due to loss of 
single water or ammonia molecules from the b- and y-ions were simulated regardless of their 
position in the ions sequence.  
A comprehensive target database of 618 mouse neuropeptides was obtained from the 
PepShop database
32
 (http://stagbeetle.animal.uiuc.edu/pepshop). This target database encompassed 
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the neuropeptides corresponding to the 103 tandem spectra studied. The neuropeptides in the 
PepShop were assembled from the known 95 mouse prohormones present in SwePep
25
 and 
UniProt
24
 complemented with NeuroPred
85
 predictions. The neuropeptides in the target database 
ranged from 2 to 223 amino acids in length because this included all known experimentally 
confirmed mouse neuropeptides as well as all possible intermediates and other peptides produced 
during the processing of prohormones. The target database of neuropeptides is available at 
http://stagbeetle.animal.uiuc.edu/pepshop/MSMSpermutationtesting. 
DATABASE SEARCH PROGRAMS AND DATABASE SEARCHING 
Three open source database search programs were used in this study: Crux (version 1.37),
44
 
OMSSA (version 2.1.8),
43
 and X! Tandem (version 2013.02.01.1).
45
 These commonly used open 
source programs were selected because the code could be modified to ensure comparable search 
parameter specification and enabled to retrieve intermediate indicators of the strength of the match 
between the observed and target or decoy spectra. The observed-target or observed-decoy spectra 
match indicators extracted from OMSSA were: number of matched fragment ions, lambda or 
Poisson mean match indicator, Poisson probability of the lambda match indicator, and 
corresponding E-value of the match (Poisson probability multiplied by the effective database size). 
The spectra match indicators extracted from X! Tandem were: number of matched fragment ions, 
intermediate convolution score (product of the intensities of the shared b- and y-fragment ions 
between experimental and theoretical spectra), hyperscore (factorial of the number of matching b- 
and y-ions multiplied by the convolution score), and E-value (calculated from the distribution of 
hyperscores scores). The spectra match indicators extracted from Crux were: number of matched 
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fragment ions, Sequest Sp score (Sp), cross-correlation score (XCorr), deltaCn score (ΔCn) and p-
value that is calculated from the Weibull distribution fitted to the XCorr scores of observed-
theoretical spectra matches.
56
 
For comparable neuropeptide identification across the three programs the following search 
parameters from our prior research
16
 were used: (1) precursor ion tolerance: 1.5 Da; (2) fragment 
ion tolerance: 0.3 Da (OMSSA and X! Tandem); mz-bin-width: 0.3 (Crux) (3) searches were 
performed with and without PTMs. The PTMs evaluated were: amidation, phosphorylation, N-
terminal acetylation, acetylation of lysine, pyroglutamination of glutamine, methylation of lysine 
and arginine residues, sulfation of tyrosine residue, and oxidation of methionine; (4) “protein” 
(OMSSA) or “enzyme: custom cleavage site” (X! Tandem and Crux) to prevent peptide cleavage 
since the detection of neuropeptides does not involve protease digestion; (5) fragment ion charge: 
default values; (6) OMSSA “ht” option was set to eight to filter database peptides that have at-least 
one theoretical fragment ion match to one of the top eight most intense peaks in the observed 
spectra; and (7) peptide mass: monoisotopic; 8) Crux p-values were computed using 1000 Weibull 
points because this information provides more accurate p-values than the default 40 Weibull 
points.
16
 
PERMUTATION APPROACH AND K-PERMUTED DECOY DATABASES 
A Monte Carlo permutation test approach based on biological, computational and statistical 
considerations was used to generate decoy sequence databases that, in turn, can be used by all 
database search programs without the need to modify the original program code. Applying the 
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same strategy used by the database search programs, candidate mouse neuropeptides within 12 Da 
of the precursor mass of the 103 studied neuropeptides were considered for permutation.  This 
resulted in 236 peptide sequences available for permutation. The 12 Da threshold enabled the 
creation of a single catalog of peptides independent of charge state tolerance because this databases 
included all peptides within a 3 m/z ion mass tolerance of the target peptide at a charge state of +4. 
This single catalog was used to create target and was the basis to generate all the decoy 
permutation databases evaluated. Figure 2.1 depicts the correspondence between the lengths of 
neuropeptides in the target database, the 103 experimental neuropeptides and the neuropeptides 
that fall within 12 Da of the 103 peptides. Decoy peptide sequences were randomly generated by 
sampling the 19 amino acids from the candidate peptide list (leucine and isoleucine were 
considered the same amino acid due to the high similarity of the neutral masses). The resulting 
libraries are comparable to those generated from a Markov model of order zero. A permutated 
database of only 10-amino acid long peptides would lead to 6.13 x 10
12
 permuted sequences. Due 
to this potential size of a database encompassing all possible permutations, a Monte Carlo 
permutation approach was used to generate a random sample of all possible sequences. These 
permuted sequences were collected into a single database after removal of duplicate peptides and 
sequences present in the target database. This procedure was used to generate k-permuted decoy 
sequence databases and the numbers of unique permuted sequences per candidate peptide (k) were: 
10
3
 (K10
3
 with 236,000 decoy peptide sequences), 10
4
 (K10
4
 with 2,360,000 decoy peptide 
sequences), 10
5
 (K10
5
 with 23,600,000 decoy peptide sequences), and 10
6
 (K10
6
 with 236,000,000 
decoy peptide sequences). The target database was appended to each of the four k-permuted 
databases to create a combined target-k-permuted decoy database. The combined database search 
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is more accurate than separate database searches and to avoid zero p-value.
65, 69, 73, 84
 This strategy 
also removed potential database size dependency of the match indicators between target and 
permuted sequences because the correct match was evaluated under the same database sizes as the 
permuted databases. 
The search of spectra against the k-permuted decoy databases produced many matches that 
were indistinguishable from each other based on the indicators reported by the programs (e.g., 
number of matched ions, hyperscore, convolution score, and E-value for the X! Tandem). Matches 
were considered “homeometric”86 when the matches had the same indicator values across 
programs and the matched peptides masses were within ±1.5 Da from each other. Matches were 
considered “heterometric” when the matches differed in at least one indicator value or the matched 
peptides masses differed by more than ±1.5 Da from each other. Figure 2.2 depicts the number of 
peptides with homeometric matches ranging from 1 to 10 for the K10
6
 k-permuted decoy database 
across the three databases search programs. Homeometric matches were counted only once while 
calculating the number of random peptides that have an indicator value equal or better than the true 
target peptide. This strategy resolved the challenge that database search programs were not able to 
differentiate between such matches that are technically redundant and ensured the calculation of 
permutation p-values that were unbiased by these effects.  
For each database search program and target sequence, the observed tandem spectra were 
searched for matches within each combined target-k-permuted decoy spectra. The permutation p-
values were estimated as the fraction of combined target-k-permuted decoy peptides, excluding 
any homeometric matches that have a matching indicator score equal or better than the score of 
target peptide.  
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A comprehensive evaluation of the k-permuted decoy approaches, programs, and peptide 
match indicators was undertaken including: (a) Search for ideal uniform simulated spectra against 
the target database using all three database search programs; (b) Search for real tandem spectra 
against the target database using all three database search programs; (c) Search for the 80 tandem 
spectra containing no PTMs against the K10
3
, K10
4
, K10
5
, and K10
6
 target-k-permuted decoy 
databases without PTM specification using all three database search programs; (d) Search for the 
80 tandem spectra containing no PTMs against the K10
5
 k-permuted database with PTM 
specification using all three database search programs; and (e) Search for the 23 tandem spectra 
containing PTMs against the K10
5
 k-permuted database with PTM specification using OMSSA 
and X! Tandem. Crux was excluded from this last comparison due to considerable amount of 
search time required. 
2.5 RESULTS AND DISCUSSION 
Results from a three step benchmarking strategy were used to evaluate the performance to 
detect neuropeptides using target-k-permuted decoy databases. First, a baseline performance was 
obtained by comparing ideal simulated spectra against a standard “target database” using the three 
database search programs. Then, observed tandem spectra were matched to a target database. 
Lastly, the observed tandem spectra were matched to different target-k-permuted decoy databases. 
The source code to generate k-permuted decoy databases is available at 
http://stagbeetle.animal.uiuc.edu/pepshop/MSMSpermutationtesting. 
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PEPTIDE DETECTION USING IDEAL SIMULATED SPECTRA AND A TARGET DATABASE 
Table 2.1 summarizes the results from the three database search programs when 103 ideal 
uniform spectra were simulated with all b- and y-ions including neutral mass losses and searched 
against the target database. The search of ideal simulated spectra demonstrated the ability of the 
database search methods to assign E- or p-values to each peptide-spectrum match in the absence of 
technical or biological noise.
16
 
The three programs matched all unmodified peptides correctly at E- or p-value < 2 x 10
-1
. 
At E- or p-value < 1 x10
-2
, OMSSA, X! Tandem, and Crux identified 80 (100%), 80 (100%), and 
73 (91.25%) peptides, respectively. This trend was consistent with previous study that compared 
Crux, OMSSA and X! Tandem.
16
 Our study confirmed the lower significance values that Crux 
computes for peptides less than 45 amino acids in length.
16
 OMSSA E-values averaged more 
significant matches than X! Tandem for the 32 peptides that were less than 13 amino acids in 
length. However, for the 48 peptides longer than 12 amino acids in length, the difference in 
significance levels of X! Tandem and OMSSA decreased on the average with 8, 18, and 22 
peptides getting lower, equal, and better significance levels for the X! Tandem than OMSSA, 
respectively.  
For the 23 neuropeptides with PTMs and an E- or p-value < 1 x 10
-1
, OMSSA, X! Tandem, 
and Crux correctly detected 23 (100%), 18 (78.26%), and 23 (100%) peptides, respectively. X! 
Tandem failed to correctly match five peptides with N-terminal acetylation modification instead 
these five peptides were matched with incorrect internal acetylation modification at 9
th
 lysine 
residue. The failure in the peptide detection of X! Tandem was only observed when multiple PTMs 
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were specified in the search specification. The five peptides were correctly detected when only N-
terminal acetylation was used in the search specification. At E- or p-value < 1 x 10
-2
, 23 (100%), 
18 (78.26%), and 22 (95.66%) peptides were detected by OMSSA, X! Tandem, and Crux, 
respectively. The three peptides that were not significant for OMSSA at E-value < 1 x 10
-4
 all had 
a pyroglutamination (Q residue) modification. Two of these peptides, somatostatin [87-100] 
(QRSANSNPAMAPRE; charge state +2) and secretogranin-2 [205-216] (QELGKLTGPSNQ; 
charge state +1), were significant for the X! Tandem and Crux at E- or p-value < 1 x 10
-4
. A nine 
amino acid long peptide secretogranin-1 [667-675] (QKIAEKFSQ; charge state +2) was not 
significant for all three programs at E- or p-value < 1 x 10
-4
, while the same peptide was missed by 
the Crux at p-value < 1 x 10
-2
. 
PEPTIDE DETECTION USING OBSERVED SPECTRA AND A TARGET DATABASE 
Table 2.2 summarizes the performance of the three database search programs when the 80 
experimental tandem spectra containing no PTMs were searched against the target database. All 
peptide assignments by the three database search methods were correct at E- or p-value < 5 x 10
-1
. 
At E- or p-value < 1 x 10
-2
, OMSSA, X! Tandem and Crux detected 80 (100%), 71 (88.75%), and 
63 (78.75%) peptides, respectively. The higher number of significant peptide detections by 
OMSSA relative to Crux was consistent with the prior reports.
16
 The three search methods were 
less accurate on 23 observed spectra with PTMs when searched against the standard target 
database (Table 2.2). From the correctly matched peptides for each program, at E- or p-value < 1 x 
10
-2
, OMSSA, X! Tandem and Crux detected 20 (86.95%), 15 (65.21%), and 17 (73.91%) 
peptides, respectively.  
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The 80 spectra without PTMs were searched against the target database using three 
database search programs and with PTM specifications. X! Tandem peptide detection significance 
levels for the 76, 3, and 1 target peptide remained unchanged, decreased, and increased, 
respectively, relative to the searches involving no PTMs. The changes in the significance levels of 
the four peptides were due to higher number of candidate peptides available in the PTM searches 
which in turn changed the estimation parameters used in the E-value computation. The OMSSA 
peptide detection significance levels decreased for the majority of the previous peptides (75 out of 
80 peptides) or remained unchanged (5 out of 80 peptides) when searches included PTMs, 
respectively. Crux peptide detection significance levels were improved when searches included 
PTMs with 65 and 29 peptide detections at p-value < 1 x 10
-2
 and < 1 x 10
-4
, respectively. 
Comparison of peptide detections across PTM scenarios indicated that at p-value < 1 x 10
-2
, 54 
peptides were detected by both scenarios, 11 peptides were detected in the PTM scenario, 9 
peptides were detected in the no PTMs scenario, and 6 peptides were not detected by either 
scenario. The target peptides with low XCorr scores remained undetected either across both 
scenarios or with PTM search. The clear positive correlation between significance level and XCorr 
score for the PTM searches relative to the searches without PTMs could be due to the higher 
number of low scoring matches in the searches with PTMs than without PTMs. The Crux 
resampling from the low scoring matches might have resulted in a shift on the distribution of 
XCorr scores towards lower scores than the target peptides XCorr scores.  
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X! TANDEM PEPTIDE IDENTIFICATION USING A K-PERMUTED DECOY DATABASE 
Table 2.3 summarizes the log10 transformed of the E-values to the target database and 
permutation p-values computed for the X! Tandem indicators: number of matched ions, 
hyperscore, E-value, and convolution score using the 80 spectra without PTMs across the four 
target-k-permuted decoy databases studied. The permutation p-values from number of matched 
ions, hyperscore and E-value showed that the X! Tandem E-values from the target database were 
dramatically underestimated (less significant) for most target peptides. Detection and significance 
level using the number of ions matched, hyperscore and E-value were almost the same across all 
target-k-permuted decoy databases. Only at the 10
6
 permutations did the p-values for number of 
ions matched started to differ from the p-values from the hyperscore and E-value match indicators. 
This trend was expected as the hyperscore is a function of the product of factorial of the number of 
matched ions and the ion intensity values and E-value is a function of the hyperscore. 
The convolution score resulted in fewer target peptide identifications with higher number 
of sequence permutations due to relative increase in the number of decoy matches with equal or 
better scores. From the K10
3
, K10
4
, K10
5
, and K10
6
 target-k-permuted decoy databases, 72 (90%), 
31 (39%), 9 (11 %), and 10 (13%) peptides were identified at p-value < 1 x 10
-2
, < 1 x 10
-3
, < 1 x 
10
-4
, and < 1 x 10
-4
, respectively. These results showed that the convolution score alone was less 
suitable to discriminate between true target and decoy matches than the hyperscore and E-value.  
Comparison of the p-values obtained from the target-k-permuted decoy number of matched 
ions, hyperscores and convolution scores suggested that roughly 10
5
 permutations were required 
for significant p-value computations using the convolution scores. Higher number of sequence 
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permutations provided better separation between the significance levels of the three indicators. 
There were 7 peptides with E-values < 10
-7
 from the target database indicating that the lower 
bound of p-values appeared to be far smaller than the limit provided by the K10
6
 permuted 
database. Comparable performance (significance level) using number of matched ions and 
hyperscore were observed with fewer permutations or lower significance thresholds. This novel 
finding suggests that more significant detections can be obtained by permuting the X! Tandem 
hyperscore and number of matched ions indicators, even with a relatively small k-permuted decoy 
database size. 
CRUX PEPTIDE IDENTIFICATION USING A K-PERMUTED DECOY DATABASE 
Table 2.4 summarizes the log10 transformed permutation p-values computed for the Crux 
match indicators: number of matched ions, XCorr, ΔCn, and Sp using the 80 spectra without PTMs 
across the four target-k-permuted decoy databases. Higher number of sequence permutations 
increased the significance values using the number of matched ions and Sp. This trend was due to 
the lower number of matched ions and Sp scores of the decoy peptide matches relative to the target 
peptides. The two non-detected peptides could be attributed to the low number of decoy candidates 
for those peptides rather than to an increase in the number of decoy peptides with equal or better 
scores. The hindering effect on the match significance of better or equal decoy matches on Sp was 
more evident with the large decoy databases at p-value < 1 x 10
-5
.  
Peptide detection was less significant when using XCorr relative to Sp and number of 
matching ions. The drop in significance level with increase in threshold and database size was due 
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to the higher number of decoy peptides reaching XCorr levels better or equal than the target 
peptides. The detection and significance computation using XCorr and ΔCn (the difference in 
XCorr between candidates) was similar across all target-k-permuted databases which reflects that 
the range of these match indicators stabilized. The range of possible XCorr values was limited by 
the number of observed spectrum peaks because the background adjustment is expected to be 
constant across permuted database sizes. This result indicates that only a relatively few permuted 
sequences are required to cover the range of XCorr values and that higher number of permutations 
offer greater precision to detect match differences. 
OMSSA PEPTIDE IDENTIFICATION USING A K-PERMUTED DECOY DATABASE 
Table 2.5 summarizes the log10 transformed permutation p-values calculated for the 
OMSSA match indicators: number of matched ions, lambda match indicator, p-value, and E-value 
using the 80 spectra without PTMs across the target-k-permuted decoy databases. Comparison 
between the target database and the permutation p-values indicated that most peptides were 
accurately estimated by OMSSA suggesting that the k-permuted database size was unimportant. 
Examination of the few peptides with underestimated E-values suggested that these peptides had 
fewer intense MS/MS ion peaks resulting in lower 75% quartile values than peptides of similar size 
with lower E-values. This result indicates that OMSSA E-values may be less reliable in the 
presence of multiple low intensity spectra peaks.  
Detection and significance computation using the number of matched ions, OMSSA p-
value and E-value indicators was identical across all k-permuted decoy databases. However, the 
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lambda parameter was less suitable than the other OMSSA match indicator to discriminate 
matches than the other match indicators. Differences in the lambda indicator for the same observed 
spectrum were mainly determined by the total number of theoretical m/z values for product ions 
and hence by the length of the decoy peptide sequence. After a relatively few permutations, the 
range of possible sequences is determined such that fewer permutations are required to determine 
the distribution of the lambda parameter than other match indicators.  
IMPACT OF PTM ON PEPTIDE IDENTIFICATION USING A K-PERMUTED DECOY DATABASE 
Searches of 80 peptides with no PTMs including the specification of common neuropeptide 
PTMs improved the significance of the detection in target-k-permuted decoy databases. Using X! 
Tandem, all 80 observed peptides were identified at p-value < 1 x 10
-5
 using the number of 
matched ions and hyperscore indicators in the K10
5
 permuted database, while convolution score 
indicator detected only 7 (8.75%) peptides. Consistent with searches without PTMs using the 
OMSSA program, when the searches included PTMs the number of matched ions and E-value 
indicators provided more significant permutation p-values than the lambda indicator. For Crux, 
specification of PTMs reduced the performance (significance levels) of the number of matched 
ions, XCorr, and Sp indicators in the K10
5
 database. The lower significances was due to 
corresponding increase in the decoy peptides with equal or better scores than the target peptides 
with increase in decoy database size when PTMs are considered in the search. Using the K10
5
 
permuted database, OMSSA and X! Tandem correctly identified the 20 and 17 of spectrum with 
PTMs as the first match, respectively. Both programs correctly identified the same 16 peptides, 6 
peptides were identified by only one program and 1 peptide was not detected by either program. 
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There were 4 peptides unmatched by X! Tandem only and the unmodified forms were matched 
outside the top 20 matches. The unmatched peptide, acetyl-YGGFMTSEKSQTPLVT, was 
undetected by OMSSA both in the target or k-permuted databases. X! Tandem was able to match 
the correct sequence, however the match has an additional amidation. Manual evaluation would 
have corrected the match as the amidation was on an unexpected amino acid and the non-amidated 
form was closer to the precursor mass then the amidated form. 
The remaining 2 peptides that were unmatched by OMSSA were both amidated. One 
peptide, SYSMEHFRWGKPV-amide, was correctly identified as the 15
th
 best match by OMSSA 
with the unamidated form providing the best match. The difference in monoisotopic mass between 
modified and unmodified was less than 1 Da. The experimental spectrum had a precursor m/z 
value of 541.70 with an assigned a 3+ charge state. At a 3+ charge state the predicted m/z values 
were 541.9294 and 541.6014 for the unmodified form and amidated forms, respectively. 
Biologically the unmodified form would be identified as a probable match since this sequence is an 
intermediate in the amidation process and the unmodified sequence is uncommon among 
neuropeptides because this form lacks the terminal G-residue after cleavage.
87
 Consequently this 
unmodified peptide could be considered a match for OMSSA. 
COMPARISON OF PEPTIDE DATABASE SEARCH PROGRAMS 
Overall the k-permuted decoy databases allowed the detection of more peptides based on 
real spectra than the use of the standard target database regardless of the database search program. 
The search of spectra against the k-permuted decoy databases produced many matches that were 
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indistinguishable from each other based on the indicators reported by the programs (e.g., number 
of matched ions, hyperscore, convolution score, and E-value for the X! Tandem). Permutation 
testing is computational demanding even with Monte Carlo sampling (Table 2.6). The increase in 
time across permutated database sizes is a consequence of the exponential increase in the number 
of sequences evaluated. However, the K10
5
 database provided adequate results and all programs 
completed the search within 35 CPU minutes using a single process Intel® Core™ i7-3770 CPU 
@ 3.40GHz. This timing is the result of single-processor searches that ignored possible parallel 
processing of individual spectra. The advantages of Monte Carlo permutation approaches to assess 
the statistical significance of neuropeptide matches could be further advanced by simultaneously 
running groups of observed spectra using parallel processing.  
An alternative approach to generate a permutated database is to perform targeted 
permutation of specific regions such as the terminal amino acids to disrupt b- and y-ion series. 
While other regions can be permuted, the advantage of permuting only the terminal peptides is that 
this strategy is independent of peptide size. The size of the required database quickly increases 
from 84,960 sequences per target peptide when one terminal position was permuted to 47,045,880 
sequences per target peptide when three terminal positions were permuted. Evaluation of terminal 
permuted databases demonstrated that this approach offered similar yet less significant matches 
than the whole sequence permuted database approach. Also, this permutation approach had the 
disadvantage of providing a large number of homeometric matches since experimental ions near 
the termini are required to differentiate the order of amino acids. Thus, results from this approach 
are not reported.  
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With the goal of accurate significance evaluation of protein matches, dynamic 
programming-related approaches have been proposed.
82, 83
 However, dynamic programming 
assumes that a problem (i.e., spectra matching) can be divided into independent components. In the 
context of tandem spectra, any division based on sequence location creates dependent components 
because changing an amino acid in any location will change both the b- and y-ion fragment series. 
Further any mass change must be balanced by a corresponding change in another part of the 
sequence such that the overall mass is within the specified tolerance of the original mass. Also, the 
implementation of these approaches limit high computational requirements by limiting the 
information considered or through analytical assumptions. These strategies resulted in non-
exhaustive libraries that could lead to biased statistical significance assessment. In one case, the 
algorithm used is location based such that the only one ion series can be used
83
 due to 
interrelationship between ion series and that precursor must remain within the preset tolerances. 
However, using only one series is not as effective as using both ion series and that one ion series 
can be more informative than the other series.
16
 In the other case, the score for a given number of 
matched peaks is assumed to encompass the score from fewer matched peaks.
82
 This assumption 
fails when different sets of peaks are being matched from the same peptide and the number of 
peaks in common changes. Both strategies do not consider the optimal starting location such that a 
peptide will be dropped from consideration when a region of the spectrum has a poor match score 
despite the higher score in other unevaluated regions. The published algorithms appear to lack 
error corrections for common problems of incorrect peak assigned due to charge state, presence of 
chimeric peptides, and missing peaks. Also, both dynamic programming strategies do not have a 
clear approach to account for peptide length that has been proven to bias the statistical significance 
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of neuropeptides identifications.
16
 Lastly, both approaches cannot be directly applied to the open 
source X! Tandem, Crux and OMSSA unlike the straightforward permutation approach proposed 
in this study. Although the lack of comparable basis challenges the benchmarking of strategies, the 
Monte Carlo permuted database approach proposed addresses the previous limitations while 
enabling simple integration to database search programs and prompt results.  
2.6 CONCLUSIONS 
The present study demonstrated that the k-permuted decoy database is an effective and 
computationally feasible approach to accurately calculate the statistics of neuropeptide matches 
from complex tandem MS datasets. Unlike other proposed methods to control multiple testing, 
such as target-decoy approaches, permutation testing provided strong control of Type I errors such 
that neuropeptides are detected at high confidence of significance. The implication of this finding 
is that an extensive decoy database is not required to accurately detect neuropeptides and this can 
be exploited to increase the speed of the search.  
This study demonstrated the relative superiority of specific detection indicators for 
database search programs. The indicators E-value, hyperscore, and Sp score from the OMSSA, X! 
Tandem, and Crux programs, respectively, performed better than other indicators. The results 
indicated that 10
5
 permutations per peptide were sufficient to provide significant peptide 
identifications. Indication of the suitability of the Monte Carlo permutation approach using 10
5
 
permutations was the capability of all three database search programs to detect all or nearly all 
neuropeptides at p-value < 10
-4
 and the absence of a trend for lower statistical significance with 
higher permutation number. A promising finding is the robust performance of the simple indicator, 
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number of matched ions between the experimental and theoretical spectra to detect peptides. This 
intuitive indicator identified the vast majority of the peptides also identified by other indicators 
such as hyperscore, Sp and E-value that rely on assumptions or parametric specifications. This 
result also highlights the importance of considering the number of matched ions when a match is 
borderline significant. The results have shown that, in conjunction with database search programs, 
the k-permuted sequence databases allowed the detection of more peptides and exhibited high 
consensus among the various indicators and database search programs.  
The permutation testing approached developed here can easily be integrated into standard 
database search programs to compute spectrum specific p-values for any indicator reported by the 
program. Through the generation of decoy peptides, the permutation approach could offer insights 
into unknown or unexpected neuropeptides (including those resulting from PTMs or 
polymorphisms or chimeras) not present in the target database. Further, the k-permuted databases 
can be generated once and shared between programs and the community. 
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2.7 FIGURES 
 
Figure 2.1. Distribution of neuropeptides length in target database peptides less than 60 amino acid 
in length are shown, 103 MS/MS peptides, and 236 peptides that fall within ±12 Da of the SwePep 
peptides. 
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Figure 2.2. Frequency (number) of spectra with 1 to 10 homeometric matches for K106 k-
permuted decoy databases across the three database search programs (X! Tandem, OMSSA, and 
Crux). 
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2.8 TABLES 
 
Table 2.1. Peptide detection significance levels using ideal simulated spectra of the 103 peptides 
with and without any post-translational modifications (PTMs) and all b- and y-ions including 
neutral mass losses against a standard target database across database search programs (OMSSA, 
X! Tandem, and Crux). 
Program PTMs Significance
a
 P ≤ 10-2b 
  0 1 2 3 4 5 ≥6  
X! Tandem None 0 0 4 4 2 6 58 74 
Amidation 0 0 0 0 0 0 9 9 
Oxidation 0 0 0 0 0 0 1 1 
Pyroglutamination 0 0 1 0 1 1 1 4 
Phosphorylation 0 0 0 0 0 1 3 4 
N-terminal acetylation 0 0 0 0 0 0 0 0 
OMSSA None 0 0 0 0 0 0 79 79 
Amidation 0 0 0 0 0 0 9 9 
Oxidation 0 0 0 0 0 0 1 1 
Pyroglutamination 0 0 1 2 1 0 0 4 
Phosphorylation 0 0 0 0 0 0 4 4 
N-terminal acetylation 0 0 0 0 0 0 5 5 
Crux None 2 5 12 52 3 1 2 70 
Amidation 0 0 2 3 2 0 2 9 
Oxidation 0 0 0 1 0 0 0 1 
Pyroglutamination 0 1 1 0 1 0 1 3 
Phosphorylation 0 0 1 2 0 0 1 4 
N-terminal acetylation 0 0 0 3 1 0 1 5 
a
Significance threshold (t) for matched to be considered significant at E- or p-value < 1 x 10
-t 
(t = 0 to >= 
6). 
b
Cumulative number of peptides with E- or p-value < 1 x 10
-2
. 
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Table 2.2. Peptide detection significance levels using experimental spectra of the 103 peptides 
with and without any post-translational modifications (PTMs) against a standard target database 
across database search programs (OMSSA, X! Tandem, and Crux). 
Program PTMs   Significance
a
 Cum N
b
 
  Miss
c
 Inc
d
 0 1 2 3 4 5 ≥6 P ≤ 10-2 
X! Tandem None 0 0 1 8 11 15 16 11 18 71 
Amidation 0 0 0 0 0 0 0 0 9 9 
Oxidation 0 0 0 0 0 0 0 0 1 1 
Pyroglutamination 0 0 0 0 1 0 1 1 1 4 
Phosphorylation 0 0 0 0 0 0 0 1 3 4 
N-terminal acetylation 0 5 0 0 0 0 0 0 0 0 
OMSSA None 0 0 0 0 1 2 1 3 73 80 
Amidation 1 0 1 0 0 0 1 0 6 7 
Oxidation 0 0 0 0 0 0 0 0 1 1 
Pyroglutamination 0 0 0 0 0 0 1 0 3 4 
Phosphorylation 0 0 0 0 0 0 0 0 4 4 
N-terminal acetylation 0 1 0 0 0 0 0 0 4 4 
Crux None 0 0 9 8 9 44 1 0 9 63 
Amidation 0 0 0 1 5 1 1 0 1 8 
Oxidation 0 0 0 0 0 1 0 0 0 1 
Pyroglutamination 0 0 1 1 0 2 0 0 0 2 
Phosphorylation 0 0 0 2 2 0 0 0 0 2 
N-terminal acetylation 0 0 0 1 1 2 0 1 0 4 
a
Significance threshold (t) for matched to be considered significant at E- or p-value < 1 x 10
-t 
(t = 0 to >= 
6). 
b
Cumulative number of peptides with E- or p-value < 1 x 10
-2
. 
c
Number of peptides missed by 
program. 
d
Number of peptides with incorrect post-translational modification assignment. 
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Table 2.3. Performance of the target and alternative k-permuted decoy databases used with the X! 
Tandem database search program using spectra from 80 unmodified neuropeptides. 
Database
a
 Indicator Significance Levels of the Permutation p-
values
b
 
Cum. Num. of 
Peptides
c
 
  0 1 2 3 4 5 ≥6 ≥10-2 ≥10-4 
Target E-value 1 8 11 15 16 12 17 71 45 
K10
3
 # ions 0 0 76 4 0 0 0 80 0 
Hyperscore 0 0 76 4 0 0 0 80 0 
Convolution 0 8 70 2 0 0 0 72 0 
E-value 0 0 76 4 0 0 0 80 0 
K10
4
 # ions 0 0 0 80 0 0 0 80 0 
Hyperscore 0 0 0 80 0 0 0 80 0 
Convolution 0 5 44 31 0 0 0 75 0 
E-value 0 0 0 80 0 0 0 80 0 
K10
5
 # ions 0 0 0 0 80 0 0 80 80 
Hyperscore 0 0 0 0 80 0 0 80 80 
Convolution 0 3 36 32 9 0 0 77 9 
E-value 0 0 0 0 80 0 0 80 80 
K10
6
 # ions 0 0 0 0 1 79 0 80 80 
Hyperscore 0 0 0 0 0 80 0 80 80 
Convolution 0 4 30 36 5 5 0 76 10 
E-value 0 0 0 0 0 80 0 80 80 
a
Target: database of 236 neuropeptide sequences; K10
3
: k-permuted decoy database size of 236,000 
peptides; K10
4
: k-permuted decoy database size = 2,360,000 peptides; K10
5
: k-permuted decoy database 
size = 23,600,000 peptides; K10
6
: k-permuted decoy database size = 236,000,000 peptides. 
b
Significance 
threshold (t) for target spectrum to be considered significant at significance thresholds  < 1 x 10
-t   
(t = 0 to 
>= 6). 
c
The cumulative number of peptides at 1 x 10
-2
 and 1 x 10
-4
 thresholds. 
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Table 2.4. Performance of the target and alternative k-permuted decoy databases used with the 
Crux database search program using spectra from 80 unmodified neuropeptides. 
Database
a
 Indicator
b
 Significance Levels of the Permutation p-
values
c
 
Cum. Num. of 
peptides
d
 
  0 1 2 3 4 5 ≥6 ≥10-2 ≥10-4 
Target p-value 9 8 9 44 1 0 9 63 10 
K10
3
 # ions 0 2 78 0 0 0 0 78 0 
XCorr 3 11 66 0 0 0 0 66 0 
Sp 0 2 78 0 0 0 0 78 0 
ΔCn 3 11 66 0 0 0 0 66 0 
K10
4
 # ions 0 0 1 79 0 0 0 80 0 
XCorr 3 10 14 53 0 0 0 67 0 
Sp 0 0 1 79 0 0 0 80 0 
ΔCn 3 10 14 53 0 0 0 67 0 
K10
5
 # ions 0 0 0 1 79 0 0 80 79 
XCorr 3 10 8 23 36 0 0 67 36 
Sp 0 0 0 1 79 0 0 80 79 
ΔCn 3 10 8 23 36 0 0 67 36 
K10
6
 # ions 0 0 0 0 2 78 0 80 80 
XCorr 3 10 9 19 22 17 0 67 39 
Sp 0 0 0 0 4 76 0 80 80 
ΔCn 3 10 9 19 22 17 0 67 39 
a
Target: database of 236 neuropeptide sequences; K10
3
: k-permuted decoy database size of 236,000 
peptides; K10
4
: k-permuted decoy database size = 2,360,000 peptides; K10
5
: k-permuted decoy database 
size = 23,600,000 peptides; K10
6
: k-permuted decoy database size = 236,000,000 peptides. 
b
# ions: 
permutation p-values computed for the number of matched b- and y-ions. XCorr: permutation p-values 
computed from the XCorr scores of the matches. Sp: permutation p-values computed from the Sp scores 
of the matches. ΔCn: permutation p-values computed using X! Tandem ΔCn. cSignificance threshold (t) 
for matched to be considered significant at p-value < 1 x 10
-t
. 
d
Cumulative number of peptides with p-
values thresholds of 1 x 10
-2 
and 1 x 10
-4
. 
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Table 2.5. Performance of the target alternative k-permuted decoy databases used with the 
OMSSA database search program using spectra from 80 unmodified neuropeptides. 
Database
a
 Indicator
b
 Significance Levels of the Permutation p-
values
c
 
Cum. Num. of 
Peptides
d
 
  0 1 2 3 4 5 ≥6 ≥10-2 ≥10-4 
Target E-value 0 0 1 2 1 3 73 80 77 
K10
3
 # ions 0 2 78 0 0 0 0 78 0 
Lambda 0 9 71 0 0 0 0 71 0 
p-value 0 2 78 0 0 0 0 78 0 
E-value 0 2 78 0 0 0 0 78 0 
K10
4
 # ions 0 0 1 79 0 0 0 80 0 
Lambda 0 5 11 64 0 0 0 75 0 
p-value 0 0 1 79 0 0 0 80 0 
E-value 0 0 1 79 0 0 0 80 0 
K10
5
 # ions 0 0 0 0 80 0 0 80 80 
Lambda 0 5 8 24 43 0 0 75 43 
p-value 0 0 0 0 80 0 0 80 80 
E-value 0 0 0 0 80 0 0 80 80 
K10
6
 # ions 0 0 0 0 2 78 0 80 80 
Lambda 0 5 8 17 18 32 0 75 50 
p-value 0 0 0 0 0 80 0 80 80 
E-value 0 0 0 0 0 80 0 80 80 
a
Target: database of 236 neuropeptide sequences; K10
3
: k-permuted decoy database size of 236,000 
peptides; K10
4
: k-permuted decoy database size = 2,360,000 peptides; K10
5
: k-permuted decoy database 
size = 23,600,000 peptides; K10
6
: k-permuted decoy database size = 236,000,000 peptides. 
b
# ions: 
permutation p-values computed for the number of matched b- and y-ions. Lambda: permutation p-values 
computed from the Poisson mean of matches. p-value: permutation p-values computed from the p-value 
reported by the OMSSA for the matches. E-value: permutation p-values computed using OMSSA E-
values. 
c
Significance threshold (t) for matched to be considered significant at p-value < 1 x 10
-t
. 
d
Incorrect: the program provided an incorrect match. 
e
Cumulative number of peptides with p-value < 1 x 
10
-2
. 
f 
Cumulative number of peptides with p-value < 1 x 10
-4
. 
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Table 2.6. Computation times given in seconds for search of 80 unmodified spectra against 
different databases using a single process Intel® Core™ i7-3770 CPU @ 3.40GHz. 
Database
a
 Database Search Program 
 Crux OMSSA X! Tandem 
Target 5 11 1 
K10
3
 7 56 41 
K10
4
 61 915 476 
K10
5
 200 1220 467 
K10
6
 2162 24475 5196 
a
Target: database of 236 neuropeptide sequences; K10
3
: k-permuted decoy database size of 236,000 
peptides; K10
4
: k-permuted decoy database size = 2,360,000 peptides; K10
5
: k-permuted decoy database 
size = 23,600,000 peptides; K10
6
: k-permuted decoy database size = 236,000,000 peptides. 
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CHAPTER III: IDENTIFICATION OF BEST INDICATORS OF PEPTIDE-
SPECTRUM MATCH USING A PERMUTATION RESAMPLING APPROACH 
Preprint of an article submitted for consideration in Journal of Bioinformatics and Computational 
Biology © 2014 copyright World Scientific Publishing Company, http://www.worldscientific.com/ 
worldscinet/jbcb 
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3.2 ABSTRACT 
Various indicators of observed-theoretical spectrum matches were compared and the 
resulting statistical significance was characterized using permutation resampling. Novel decoy 
databases built by resampling the terminal positions of peptide sequences were evaluated to 
identify the conditions for accurate computation of peptide match significance levels. The 
methodology was tested on real and manually curated tandem mass spectra from peptides across a 
wide range of sizes. Indicators from complementary database search programs were profiled. The 
permuted decoy databases improved the calculation of the peptide match significance compared to 
the approaches currently implemented in the database search programs that rely on distributional 
assumptions. Permutation tests using p-values obtained from software-dependent matching scores 
and E-values outperformed permutation tests using all other indicators. The higher overlap in 
matches between the database search programs when using end permutation compared to existing 
approaches confirm the superiority of the end permutation method to identify peptides. The 
combination of effective match indicators and the end permutation method is recommended for 
accurate detection of peptides. 
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3.3 INTRODUCTION 
Mass spectrometry discovery has revolutionized proteomic research enabling the 
characterization and quantification of hundredths of peptides from samples ranging in size and 
complexity.
74-79
 In tandem mass spectrometry (MS/MS) experiments, the peptides present in the 
sample can be identified by sequence database search programs.
16, 88
 These programs attempt to 
match the fragment ions from the observed spectra with the fragment ions from theoretical spectra 
generated from the known or predicted peptide sequences in the target database. Each observed-
theoretical spectra match is assigned scores that reflects the similarity between both spectra. 
Subsequently, these scores are converted into a measure of the statistical evidence supporting the 
match.
41, 46
 
Two related components, the match score and the statistical significance assigned to the 
score, influence the capability to detect peptides. Database search software differ in the algorithms 
and assumptions to assess the observed-theoretical spectra match leading to different mating score 
indicators (e.g., number of matched fragment ions, cross-correlation) and different methods to 
assess statistical significance of the match. The comparative effectiveness of the scores to capture 
the match has not been evaluated. 
One commonly used approach to convert specific observed-theoretical spectra match score 
into a statistical significance value encompasses fitting a specific parametric distribution to all the 
match scores attained from the target database
43, 45
 or from decoy peptides generated from the 
target database matches.
56
 Alternatively, significance values can be obtained in a non-parametric 
fashion from the decoy peptides.
69
 A previous comparative study of the database search programs 
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demonstrated that, for some peptides, detection using significance value estimation approaches 
implemented in the database search programs remains challenging.
16
 This situation can be traced 
back to the low significance levels obtained with existing approaches particularly for short peptides 
under 15 amino acids in length.
16
 
The challenges of peptide identification using existing approaches include false negatives 
due to match significance levels that do not surpass the minimum detection threshold, false 
positives due to incorrectly spectra match surpassing the minimum threshold, and missed peptides 
due to sample complexity leading to multiple peptides present in the single tandem spectrum (also 
known as chimeric spectra).
16
 The bias introduced by existing approach has major impact in small 
peptides. These peptides are unlikely to be identified at high significance levels by most database 
search programs due limited number of fragment ions to accumulate high matching scores.
16, 20, 58
 
Also, tandem spectra that have incomplete fragmentation and noise peaks can result in matches 
with low scores that can be indifferent to the random matches, thus, resulting in low significance 
levels.
16, 80
 Likewise, increases in the effective search database size (such as those rising from the 
consideration of post-translational modifications) can reduce the sensitivity of the algorithms to 
detect peptides at accurate significance levels.
20
 
In the target-decoy approach, observed spectra are matched to theoretical spectra from 
reverted or reshuffled sequences from the target database together with the original target 
sequences.
65
 The target-decoy approach aims at avoiding stringent significant threshold to control 
for multiple testing across peptides.
72, 73
 However, for small peptides, most decoy database 
construction methods produce few spectra that have more extreme matches that artificially inflates 
the significance levels. Other decoy databases construction methods that exploit the capability of 
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resampling approaches to generate null hypothesis while controlling the experiment-wise error rate 
should be evaluated.  
The aims of this study were: (1) to compare indicators of observed-theoretical spectra 
matches and characterize the accuracy of the resulting statistical significance using permutation 
testing, (2) to develop novel decoy databases including resampling of terminal positions in the 
peptide sequence and identify the conditions for accurate computation of match significance levels, 
and (3) to demonstrate the application of the novel decoy approach using popular database search 
programs. 
3.4 THEORETICAL-OBSERVED SPECTRA MATCH INDICATORS 
Table 3.1 lists the observed-theoretical spectrum match indicators evaluated and 
corresponding database search programs: Crux (version 1.37),
44
 OMSSA (version 2.1.8),
43
 and X! 
Tandem (version 2013.02.01.1).
45
 These programs were selected because their open source nature 
allowed the retrieval of intermediate match indicators through modification of the source code. 
Database search specifications were: (1) mass type: monoisotopic; (2) fragment ion charge: 
default values; “mz-bin-width”: 0.3 (Crux); (3) no post-translational modifications; (4) enzyme: 
“whole protein” (OMSSA) or custom cleavage site to avoid cleavage of the provided neuropeptide 
database (Crux and X! Tandem); (5) precursor ion tolerance: 1.5 Da; (6) fragment ion tolerance: 
0.3 Da (OMSSA and X! Tandem); and (7) OMSSA “ht”: 8 to consider only those database 
peptides that had one or more fragment ion matching including one of top 8 highest fragment ion 
peaks in the observed spectrum. The selected specifications follow program settings previously 
used to evaluate the ability of the database search programs to identify peptides.
16
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3.5 OBSERVED SPECTRA, TARGET AND DECOY DATABASES 
The performance of alternative indicators to assign the statistical significance to spectra 
matches was investigated on a murine linear ion trap (LTQ) tandem spectra dataset.
25
 Spectra and 
peptide identification were obtained from the SwePep database (http://www.swepep.org).
25
 The 
tandem spectra dataset consisted of 80 observed tandem spectra from neuropeptides without post-
translational modifications. The majority of the peptides (92%) had precursor charge states +2 or 
+3. The target database included the 80 peptides with observed spectra studied and all other 
peptides that could have been produced from the known 95 mouse prohormones including those 
that produced the 80 peptides studied. The exhaustive list of target peptides was obtained from the 
PepShop
32
 database (http://stagbeetle.animal.uiuc.edu/pepshop) including information from the 
SwePep, UniProt,
24
 and NeuroPred.
85
 
To understand the performance of the software under best conditions, optimal spectra were 
simulated for the peptides in the target database using corresponding precursor charge states. For 
each spectrum, all b- and y- fragment ions with +1 charge state were simulated with uniform 
intensity. Additional peaks due to loss of single ammonia or water molecule were simulated when 
the b- or y-ions sequence contained a water or ammonia loosing amino acids anywhere in the 
sequence.
16
 
The characterization of the significance of the spectral match based on various indicators 
relied on a decoy database generated using permutation.
84
 A single target database that was used 
for all database search programs was created by selecting all peptides within 12 Da (corresponding 
to 3 m/z ion tolerance with a +4 charge state) of the precursor mass for each tandem spectrum. This 
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mass limit results from the database search programs preselecting candidate peptides based on 
peptide mass and user-defined mass tolerances. Permutations of each target candidate sequence 
residues at the N- and C-terminal ends were used to populate the decoy database. This terminal 
permutation generated decoy peptides that were more similar to their target peptides yet disrupted 
the pattern of b- and y-fragment ions that are used in matching the observed and theoretical spectra. 
The terminal regions were selected because it was considered that the ions from the terminal 
regions had better sensitivity than the ions from the central region of peptide. Leucine and 
isoleucine were treated as the same amino acid in all permutations and comparisons between 
candidate and permuted sequence. 
From the termini permutation strategy, three decoy databases: Ends1, Ends2 and Ends3 
were evaluated. Ends1 encompasses 236*(19 N-terminal amino acids)*(19 C-terminal amino 
acids) = 236*360 = 84,960 decoy peptides; Ends2 encompasses 236*(19*19 N-terminal amino 
acids)*(19*19 C-terminal amino acids) = 236*130320 = 30,755,520 decoy peptides; and Ends3 
encompasses 236*(19*19*19 N- terminal amino acids)*(19*19*19 C-terminal amino acids) = 
236*47,045,880 =1,120,027,680 decoy peptides. Separate permuted databases were created for 
each observed spectra in Ends3 due to inability of the database search programs to adequately 
handle the size of the permuted decoy database. The target database was appended to each of the 
Ends decoy databases for the combined target-decoy search strategy. The merging of the target and 
decoy databases provided unbiased p-value estimates and avoided zero p-values.
84
 
For each observed-theoretical spectra match indicator, the permutation p-values were 
computed as the relative frequency of the sum of the matches in the target-decoy database that had 
indicator values equal or better than the observed-target spectra matches. A Bonferroni adjusted 
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threshold p-value < 1 x 10
-4
 based on a 1% experiment-wise error rate (0.01/80 ≈ 1 x 10-4) was 
used to compare performance of the different indicators. A sensitivity analysis enabled the 
assessment of the impact of the p-value threshold on the capability of match indicators to detect the 
peptides. The limited number of observed and annotated spectra prevented unbiased analysis using 
receiver operating characteristic (ROC) curve. 
3.6 RESULTS AND DISCUSSION 
A threefold-strategy was used to characterize the performance of spectra match indicators 
from database search programs to detect peptides. First, optimal simulated spectra were searched 
against the target database to obtain a baseline performance in the absence of data quality issues 
such as presence of noise peaks, missing signal peaks, and low signal-to-noise ratio. Second, real 
spectra were searched against the target database to study the influence of data quality issues on 
peptide detection significance levels relative to the baseline performance. Third, the performance 
of the match indicators to detect peptides in realistic scenarios using End-permuted decoy 
databases was demonstrated. 
PEPTIDE DETECTION BENCHMARKS USING OPTIMAL AND REAL SPECTRA AGAINST THE 
TARGET DATABASE 
Table 3.2 summarizes the number of peptides detected by the three database search 
programs at various significance E- or p-value thresholds when optimal uniform simulated spectra 
and real tandem mass spectra were searched against the target database. 
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For the ideal simulated spectra, the three programs accurately detected all peptides at E- or 
p-value < 1 x 10
-1
. At E- or p-value < 1 x 10
-4
, the Crux, OMSSA, and X! Tandem detected 9 
(11.25%), 80 (100%), and 72 (90.0%) peptides, respectively. The significance levels of the X! 
Tandem E-values increased linearly with increase in peptide length and only peptides greater than 
8 amino acids in length (hyperscore > 40) reached a significance level of E-value < 1 x 10
-4
. 
OMSSA E-values were less correlated with peptide length or number of matched b- and y-ions. 
The minimum E-value was 1 x 10
-6
 and corresponded to an 11 amino acid-long peptide that had a 
+2 precursor charge state spectrum. The lower significance level of Crux peptide matches, relative 
to the OMSSA and X! Tandem, have been confirmed previously.
16
 At a less stringent threshold p-
value < 1 x 10
-2
, Crux identified 73 (91.25%) peptides with seven peptides between 7 to 14 amino 
acids in length undetected. 
Crux, OMSSA, and X! Tandem correctly matched 10 (12.5%), 77 (96.35), and 45 (56.3%) 
real spectra, respectively, at E- or p-value < 1 x 10
-4
. A large number of peptides (44) were 
detected with a p-value < 10
-3
 indicating the previously noted difficulty of obtaining significant 
matches with Crux.
16
 The spectra quality features such as missing peaks, noise peaks and low 
intensity peaks tended to reduce the positive correlation that was observed between peptide length 
and E-value in the optimal simulated scenario. 
Higher number of Weibull points (XCorr scores) were correlated with more significant p-
values in Crux.
16
 Consistent with prior work, the increase in the number of Weibull points from 
10
3 
to 10
4
, and 10
5 
resulted in 24 and 10 more peptides that reached p-value < 1 x 10
-4
 relative to 
the 10
3
 scenario, respectively. However, 17 and 40 more peptides had p-value > 1 x 10
-2
 with 10
4
 
and 10
5
 Weibull points, respectively, than with 10
3
 points (data not shown). Further investigation 
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uncovered that peptides that did not reach the significance threshold were affected by the “mz-bin-
width” (fragment ion tolerance) parameter. Increasing the “mz-bin-width” values from 0.3 to 
1.0005 increased XCorr scores, and consequently, reduced the number of peptides that had p-value 
> 1 x 10
-2
 (figure 3.1). Thus, the 0.3 specification appears to provide more conservative results. 
However, to use comparable search specification for the three database search programs, from this 
point onwards, all Crux results were calculated using the more conservative 0.3 “mz-bin-width”.  
PEPTIDE DETECTION USING REAL SPECTRA AGAINST THE END DECOY DATABASE 
The detection of peptides from observed real spectra when matched against the End-
permuted decoy database improved relative to the standard comparison against a target database. 
Figure 3.2 depicts the distribution of the effective database size corresponding to each observed 
spectra for the three database search programs when two (Ends2) or three (Ends3) terminal 
residues were permuted. The patterns in these box plots showed that X! Tandem evaluated more 
decoy sequences than the Crux and OMSSA. 
For each peptide, some matches of the observed spectrum against the decoy database 
spectra were indistinguishable from each other in terms of all indicators (e.g., the number of 
matched fragment ions, XCorr score, and Sp score). This is because for each peptide, the Ends2 
and Ends3 decoy databases had dimer and trimer residue combinations with similar total 
monoisotopic masses. These numerically indistinguishable matches were counted as one when 
calculating the permutation p-values to avoid biases towards any one database search program. 
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Table 3.3 summarizes the number of peptides matched at different log10-transformed 
permuted p-value significant levels across match indicators and database search programs for the 
Ends1, Ends2, and Ends3 decoy databases.  
X! Tandem 
The level of significance of the matches to the decoy databases increased from Ends1 to 
Ends2 and stabilized between Ends2 and Ends3 decoy databases (Table 3.3). The Ends2 and 
Ends3 decoy databases detected 34.95 to 38.70% more peptides than the target database. Overall, 
the X! Tandem indicator convolution score had the lowest detection rate among all indicators 
suggesting that the convolution score alone is inadequate to discriminate between true target and 
false decoy matches. Detections and significance levels were similar for the hyperscore and E-
value indicators. Furthermore, detection rate was comparable between hyperscore and the number 
of matched ions across the three End decoy databases. End decoy databases improved peptides 
detection relative to the target database for number of matched ions, hyperscore and E-value 
indicators.  
The peptides that were not detected by the hyperscore were also not detected by the number 
of matched ion indicator. The decoy database size was not correlated with the significance level or 
capability to detect the peptide. Of the undetected peptides, 2 peptides were not detected by the 
Ends2 and Ends3 databases. Meanwhile five undetected peptides in the Ends2 database were 
significant with the Ends3 database, four other peptides that were significant in the Ends2 database 
were not detected (became non-significant) in the Ends3 decoy database. The non-significant 
peptides in the Ends3 database were either non-significant or marginally significant in the target 
database.  
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Table 3.4 summarizes the number of peptides detected in the target and Ends3 decoy 
databases, target only, Ends3 only, and missed by both databases when the number of matched 
ions and hyperscore indicators are considered. The Ends3 decoy database detected most peptides 
(42 out of 45) that were significant in the target database in addition to the 32 peptides that were 
missed by the standard target database. The performance of the number of matched ions and 
hyperscore was comparable. The higher significance of the matches resulting from the 
consideration of the hyperscore relative to all other X! Tandem indicators can be attributed to the 
use of peak intensity in the scoring and the theoretical spectrum synthesis process.
20
 
Crux 
Peptide detection and significance levels were similar for the XCorr and ΔCn across Ends2 
and Ends3 decoy databases. The XCorr and ΔCn detected 33 (41.25%) and 35 (43.75%) peptides 
in the Ends2 and Ends3 decoy databases, respectively (Table 3.3). The lower peptide detection rate 
of XCorr and ΔCn with decoy databases indicates that XCorr and ΔCn are less suitable than the 
other indicators (Sp and number of ions). Overall, the Sp indicator identified 2 and 4 more peptides 
(p-value < 1 x 10
-4
) than the number of matched ions indicator in Ends2 and Ends3, respectively 
(Table 3.3).  
Combining the number of matched ions or Sp indicators with the End decoy databases 
improved the peptide detection relative to the target database alone. The Ends2 and Ends3 
databases had 67.5 to 83.75% peptide detection rate compared to 12.50% with the target database 
with both indicators. The number of matched ion indicator missed more peptides (23) than the Sp 
indicator (19). The Ends3 permuted database detected 51 peptides missed by the standard target 
database using Sp indicator (Table 3.4).  
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OMSSA 
Table 3.3 summarizes the log10-transformed p-values for the OMSSA match indicators: 
number of matched ions, lambda, Poisson p-value, and E-value. Detections and significance levels 
were identical for the Poisson p-value and E-value indicators, and only E-value indicator would be 
considered in further discussion. The lambda indicator overall detected lower number of peptides 
than the number of matched ion and E-value indicators suggesting that the lambda alone is 
inadequate to discriminate between target and decoy matches. The Ends2 and Ends3 decoy 
databases provided further discrimination between the number of matched ions and E-value 
indicators, with significance levels and peptide detection rate in the decoy database higher than the 
target database when the E-value indicators was considered. The E-value indicator provided more 
true detections across significance thresholds than the number of matched ions and lambda 
indicators.  
Comparison among Database Search Indicators 
Table 3.4 lists the number of peptides identified by the target and Ends3 decoy, target only, 
Ends3 decoy only, and not identified by either database when the number of matched ions and E-
value indicators are considered. Meanwhile the number of ions and E-value indicators detected 3 
peptides using the Ends3 decoy database that were missed by the target database, these indicators 
detected 10 and 7 peptides, respectively using the target database that were missed by the decoy 
database. Approximately, 88% peptide detections were shared by the target and Ends3 databases 
using the E-value indicator. 
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3.7 COMPARISON OF SPECTRA MATCH INDICATORS AND DATABASE SEARCH 
SOFTWARE 
Figure 3.3 depicts the number of peptides detected by one, two or all three database search 
programs when the number of matched ion and best score indicator from each of the three 
programs was used to compute the p-value. The best score indicator was defined as the indicator 
that exhibited the highest difference between the target and decoy peptides. The best spectra match 
indicators were E-value for OMSSA, hyperscore for X! Tandem, and Sp for Crux. 
The Ends decoy databases supported higher consensus among the three programs when 
compared to the target database. For the Ends3 decoy database, all three programs detected slightly 
less peptides together when considering the number of matched ions compared to the best indicator 
(50 vs. 56). A similar number of peptides were detected by any two programs using the number of 
matched ions than the best score indicator (72 vs. 73). OMSSA and Crux detected more peptides 
with best indicator than the number of matched ion indicator and X! Tandem detected similar 
peptides with the number of matched ions and the hyperscore. Using either the number of matched 
ions or best score indicator, X! Tandem detected more peptides than OMSSA and Crux and 
OMSSA detected more peptides than Crux. 
The computational time of the searches was calculated on a computer with 3.40 GHz Intel 
Core i7-3770 processor. Searching the target database only using Crux (using 1000 Weibull 
points), X! Tandem and OMSSA averaged 1.14, 0.013, and 0.14 seconds per spectrum, 
respectively.  Crux averaged 0.04, 3.54 and 40.65 seconds for Ends1, Ends2 and Ends3 decoy 
databases, respectively. X! Tandem averaged 0.15, 6.54, and 116.26 seconds per spectrum for 
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Ends1, Ends2 and Ends3 decoy databases, respectively. OMSSA averaged 0.34, 21.72, and 604.00 
seconds per spectrum for Ends1, Ends2 and Ends3 decoy databases, respectively. The longer 
search time for the X! Tandem and OMSSA using the Ends3 decoy database relative to Ends2 
database could be due to the searching of separate decoy databases for each spectrum in addition to 
the larger database size of the Ends3 decoy database. Furthermore, the comparisons of the peptide 
detection rate between the Ends2 and Ends3 database suggest that detection performance similar to 
the Ends3 database could be obtained using a smaller random sample of the decoys in the Ends3 
database. Overall, the dramatic improvement in the peptide identification highlights the efficacy of 
the terminal residue permutation decoy database. 
3.8 CONCLUSIONS 
The present study demonstrated that the spectra match indicators Sp (Crux), hyperscore (X! 
Tandem) and E-value (OMSSA) with a terminal residue permutation decoy database enabled 
effective detection of peptides compared to target database. The Ends decoy databases improved 
the consensus among database search programs to identify peptides. The End decoy databases can 
be integrated to other database search programs. The new candidate decoy peptides resulting from 
the permutation can also be used to discover novel peptides.  
In the present study, Ends decoy databases were generated from subset of target database 
peptides that were within 12 Da of the observed spectra precursor masses since database search 
programs initially filter candidate peptides based on precursor mass. The approach can be extended 
to any number of peptides, types of peptides and other database search programs. This could be 
accomplished by generating the required number of permuted peptides from peptide-spectrum 
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matches (PSMs) obtained by searching observed spectra against the target database using the 
desired database search program.  
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3.9 FIGURES 
 
Figure 3.1. Box plots of Crux XCorr scores (a) and number of peptides correctly identified at 
different -1*log10-transformed Weibull p-values (b) using “mz-bin-width” values of 0.3, 0.5, 0.7, 
and 1.0005. 
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Figure 3.2. Box plots depicting the distribution of number of candidate decoy peptides within 
precursor mass tolerance per queried observed peptide considered by Crux, OMSSA, and X! 
Tandem for the (a) Ends2 and (b) Ends3 permuted decoy databases. 
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Figure 3.3. Distinct and shared number of peptide detected in the Ends3 decoy database using a) 
the number of matched ions or b) the best indicator for each database search program (OMSSA E-
value, Crux Sp score, and X! Tandem hyperscore). 
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3.10 TABLES 
Table 3.1. Crux, X! Tandem, and OMSSA match indicators used. 
Programs Indicators 
Crux Number of matched b- and y-fragment ions 
 SEQUEST preliminary (Sp) score 
 Cross-correlation (XCorr) score 
 DeltaCn (ΔCn) score 
 p-value: computed from the Weibull distribution using 10
3
 XCorr scores 
X! Tandem Number of matched b- and y-fragment ions 
 Convolution score 
 Hyperscore 
 E-value: computed assuming hypergeometric distribution for 
hyperscores 
OMSSA Number of matched b- and y-fragment ions 
 Lambda or Poisson mean 
 Poisson p-value 
 E-value: Poisson p-value multiplied by effective database size 
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Table 3.2. Number of peptides matched at various significance levels of the log10-transformed E- 
or p-values when the optimal simulated spectra and real tandem spectra were searched against the 
standard target database. 
Program Spectra Log10-transformed p-values Peptides (%) 
at < 1 x 10
-4
   0
a
 1 2 3 4 5 ≥6 
Crux Optimal 2 5 12 52 3 1 5 11.3 
Real 9 8 9 44 1 0 9 12.5 
OMSSA Optimal 0 0 0 0 0 0 80 100.0 
 Real 0 0 1 2 1 3 73 96.3 
X! Tandem Optimal 0 0 4 4 2 6 64 90.0 
 Real 1 8 11 15 16 11 18 56.3 
a
Significance threshold (t) for matches to be significant at p-value <1 x 10
-t
. 
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Table 3.3. Number of peptides detected by spectra match indicators from database search 
programs across log10-transformed p-values levels of the computed using the End decoy databases. 
Programs Database
a
 Indicators Log10-transformed p-values Pep. 
< 1 x 10
-4c
    0
b
 1 2 3 4 5 ≥6 
X! Tandem Ends1 # of ions 0 8 72 0 0 0 0 0 
 
 Convolution 0 25 55 0 0 0 0 0 
 Hyper/E-value 0 9 71 0 0 0 0 0 
 Ends2 # of ions 0 0 0 7 65 8 0 73 
  Convolution 0 2 20 41 17 0 0 17 
  Hyper/E-value 0 0 0 4 67 9 0 76 
 Ends3 # of ions 0 0 0 6 29 44 1 74 
  Convolution 0 0 1 26 31 22 0 53 
  Hyper/E-value 0 0 0 5 20 51 4 75 
Crux Ends1 # of ions 0 20 60 0 0 0 0 0 
  Sp 0 19 61 0 0 0 0 0 
  XCorr/ΔCn 4 30 46 0 0 0 0 0 
 Ends2 # of ions 0 0 0 15 65 0 0 65 
  Sp 0 0 0 13 67 0 0 67 
  XCorr/ΔCn 1 6 12 28 33 0 0 33 
 Ends3 # of ions 0 1 1 24 27 27 0 54 
  Sp 0 1 1 20 28 30 0 58 
  XCorr/ΔCn 0 3 17 25 23 12 0 35 
OMSSA Ends1 # of ions 0 16 64 0 0 0 0 0 
  Lambda 2 29 49 0 0 0 0 0 
  p-value/E-value 0 14 66 0 0 0 0 0 
 Ends2 # of ions 0 0 0 22 58 0 0 58 
  Lambda 0 6 15 25 34 0 0 34 
  p-value/E-value 0 0 0 11 69 0 0 69 
 Ends3 # of ions 0 0 0 10 51 19 0 70 
  Lambda 0 0 0 17 43 20 0 63 
  p-value/E-value 0 0 0 7 33 40 0 73 
a
Ends1: the last one N- and C-terminal amino acids were permuted (decoy peptides: 236*360=84,960); 
Ends2: the last two N- and C-terminal amino acids were permuted (decoy peptides: 
236*130320=30,755,520); Ends3: the last three N- and C-terminal amino acids were permuted (decoy 
peptides: 47,045,880). 
b
Significance threshold (t) for matched to be considered significant at p-value < 1 x 
10
-t
. 
c
The number of peptides detected at p-value < 1 x 10
-4
. 
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Table 3.4. Number of peptides detected by spectra match indicators from database search 
programs using the target and Ends3 decoy databases. 
Program Indicators Number of peptides detected in Ends3 permuted 
and target databases 
  PT
a
 P T None 
Crux # of ions 7 47 3 23 
Sp 7 51 3 19 
OMSSA # of ions 67 3 10 0 
 E-value 70 3 7 0 
X! Tandem # of ions 42 32 3 3 
 Hyperscore 43 32 2 3 
a
PT: peptides detected at  p-value < 1 x 10
-4 
in both target and Ends3 databases; P: peptides detected at  p-
value <1 x 10
-4 
in Ends3 database only; T: peptides detected at  p-value <1 x 10
-4
 in the target database 
only; None: missed peptides (p-value > 1 x 10
-4
) in both databases. 
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CHAPTER IV: EVALUATION OF RESAMPLING APPROACH FOR THE 
TRYPTIC PEPTIDE IDENTIFICATION IN TANDEM MASS SPECTROMETRY 
EXPERIMENTS USING DATABASE SEARCH APPROACH 
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4.2 ABSTRACT 
A novel resampling approach was integrated with the OMSSA database search program. 
Complete peptides sequences that were within a 3 Da precursor mass tolerance of the observed 
spectrum mass were randomly generated. The approach was tested on 5,806 tryptic tandem mass 
spectra (http://www.ludwig.edu.au).
20
 The performance of the OMSSA’s E-value indicator and k-
permutation decoy database was validated and compared by filtering peptides matches using a 5% 
false discovery rate estimated from the target database and target-decoy database searches. The 
conventional receiver operating characteristics (ROC) curve analysis was used to study the tradeoff 
between true positive rate and false positive rate regardless of any specific threshold. The k-
permuted database showed better sensitivity and classification performance relative to the OMSSA 
E-value. A higher peptide detection rate was achieved due to better separation of false negative 
matches with less number of matched ions and large OMSSA’s E-values from the true negatives 
and false positive matches. ROC curves analysis indicated that the k-permuted decoy database had 
performance comparable with OMSSA E-value at various thresholds with an area under the curve 
(AUC) of 0.95 and 0.94, respectively. 
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4.3 INTRODUCTION 
The bottom-up shotgun approach enables high throughput proteins and peptide 
identifications from complex protein mixtures using tandem mass spectrometry (MS/MS).
14
 In the 
shotgun approach, proteins in the complex mixture are enzymatically digested into peptides usually 
with trypsin. The resulting peptides are separated using techniques such as reverse phase 
chromatography and subsequently introduced into the mass spectrometer. These peptides are 
ionized and the mass-to-charge (m/z) ratios are measured to generate the first MS scan. The peptide 
ions are further fragmented inside the mass analyzers and the m/z values of the fragments are 
measured to generate MS/MS (tandem) spectra.
41
  
Database search approaches are commonly used to infer the amino acid sequences 
corresponding to the acquired tandem spectra
41
 including SEQUEST,
89
 Mascot,
46
 OMSSA,
43
 
X!Tandem,
45
 and Crux.
44
 For any observed experimental spectra, these programs predict the 
peptides resulting from the enzymatic digestion of protein sequences compiled in a database, 
generate in silico theoretical spectra from the peptides that fall within mass tolerance of the 
observed spectra, and match the observed spectra against theoretical spectra. Different database 
search programs use different scoring schemes to rank the observed-theoretical spectra matches 
and typically the best match or hit is listed as the most likely identifier peptide.
41
 The database 
search programs can be grouped into probabilistic and empirical based based on the scoring 
schemes.
67
  
The identification of peptides from tandem mass spectra remains challenging.
16, 90
 The 
correct peptide identification (true positive) rate is reported to range from 5 to 50%.
20, 65, 67
 The 
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remaining spectral assignments are either false positive (incorrect), or false negatives (missed).
90
 
Factors that could lower the true positive rate include presence of low informative product ions due 
small size of fragmented peptides,
16, 20, 91
 incomplete fragmentation,
16, 39, 80
 high intensity noise 
peaks relative to the signal peaks,
26
 effective database size,
49
 and chimeric events due to the 
fragmentation of more than one peptide ions to generate tandem spectra.
16
   
The method to evaluate the statistical significance of the match between the observed and 
theoretical spectra could aid in augmenting the true positive rate of peptide detection. The k-
permuted decoy database approach has been proven to increase the true positive rate of 
neuropeptide detection compared to approaches implemented in the database search programs.
88
 
The benefits of the Monte Carlo permuted decoy strategy to identify tryptic peptides have not been 
assessed. Unlike neuropeptides, tryptic peptides in general require trypsin digestion and show 
different fragmentation patterns due to presence of C-terminal basic residues. A public dataset of 
tryptic digest peptides from the plasma and serum proteins is available at 
(http://www.ludwig.edu.au).
20
 The proteins were digested with trypsin enzyme and resulting 
peptides were analyzed using LCQ Deca XP ion trap mass spectrometer (Thermo-Finnigan, San 
Jose, CA, USA). In this dataset peptide assignments to 671 tandem mass spectra identified by the 
seven programs were independently validated by the experts in different laboratories.
20
 The known 
peptide assignments were used in this study to evaluate the performance of the OMSSA and k-
permuted decoy database. 
The overall goal of this study is to evaluate the relative advantages of the k-permuted decoy 
database approach to identify tryptic peptides. Supporting aims were: (1) to evaluate the effectivity 
of the k-permuted decoy database approach to effectively use larger tryptic MS/MS datasets; (2) to 
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evaluate the ability of the k-permuted decoy database approach to discriminate between correct and 
incorrect peptide assignments on MS/MS datasets in which many spectra are either missed or 
incorrectly matched; (3) to evaluate the performance of the k-permuted decoy database approach 
and standard approach in OMSSA using commonly used the target-decoy search strategy to 
estimate False Discovery Rate (FDR); and (4) to evaluate the performance of the approaches using 
conventional Receiver Operating Characteristics (ROC) curves. 
4.4 MATERIALS AND METHODS 
DATASET AND TARGET DATABASE  
The performance of the k-permuted decoy database approach was evaluated on annotated 
experimental tandem mass spectra obtained from the Human Plasma Proteome Project samples.
20
 
The plasma and serum proteins were digested with trypsin and resulting peptide mixture was 
separated using liquid chromatography (Agilent 1100 capillary column). The peptides were 
analyzed on an LCQ Deca XP ion trap mass spectrometer (Thermo-Finnigan, San Jose, CA, USA) 
using electrospray ionization source. This dataset with validated set of peptide assignments was 
downloaded from http://www.ludwig.edu.au and consisted of 5,806 tandem mass spectra (.dta 
format) that were analyzed using seven programs including Mascot, SEQUEST, PeptideProphet, 
Sonar, X!Tandem, Spectrum Mill, and Spectrum Mill (tag).
20
 The dataset consisted of 671 
annotated and 5,135 unannotated spectra. The known peptide identities for the 671 spectra ranged 
from 5 to 41 amino acids in length. Of the 671 spectra: 218, 360, and 93 had precursor charge 
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states of +1, +2, and +3, respectively. The dta spectral files were converted in to a single mascot 
generic format (mgf) file using a python script. 
The spectra were searched against a target protein sequence database containing 68,711 
protein entries downloaded from the RefSeq (ftp://ftp.ncbi.nih.gov/refseq; release 61 September 9, 
2013). A reversed decoy database was also created by reversing the protein sequences in the target 
database. These reversed decoy sequences were appended at the end of target database for the 
combined target-decoy search strategy to estimate the false discovery rate. 
DATABASE SEARCH PROGRAM AND DATABASE SEARCH STRATEGY 
OMSSA (version 2.1.8), an open source program was used for the identification of peptides 
and to evaluate the performance of the k-permuted decoy database. This program was selected due 
to its relatively better performance for the small peptides and spectra containing noise.
16, 88
 The 
program reported the number of matched ions between observed and theoretical spectra and 
significance values (E-value and p-value) for the PSMs. OMSSA uses a Poisson parametric 
distribution to compute significance values. The source code of OMSSA was modified to obtain 
the effective database size and Lambda (parameter for the Poisson distribution) for each spectrum. 
In this study, the OMSSA’s E-value indicator of the match quality was evaluated. The E-value 
indicator was selected based on previous studies (chapters II and III) in which E-value 
outperformed the other indicators reported by OMSSA.  
The following search specifications were used for the database searches: (1) precursor mass 
tolerance: 3.0 Da; (2) fragment mass tolerance: 0.5 Da; (3) variable PTMs: Oxidation of 
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Methionine and Carbamylation of Lysine; (4) mass type: monoisotopic; (5) enzyme: “trypsin” for 
the forward and reverse protein sequence databases or “whole” option to prevent cleavage of the 
provided k-permuted decoy database; (6) Digestion: partial digestion of protein sequence database 
that allows one non-tryptic termini in the resulting peptides; (7) maximum number of missed 
cleavages: 1; (8) minimum peptide length: 4; (9) minimum number of m/z peaks a spectrum must 
have: 2; (10) Option “ht”: at-least one of theoretical spectra peak must match to one of the eight 
most intense experimental spectra peak; and (11) the upper limit on the maximum peptide length 
(i.e., 40 amino acids) for the semi-tryptic digestion was disabled. 
GENERATION OF PERMUTED DECOY DATABASE 
The Monte Carlo permutation approach was used to generate k-permuted decoy peptides 
by randomly sampling a subset (k) of decoy peptides for each spectrum. The decoy peptides are 
sequences of amino acids that are not present in the target database. The match of a spectrum 
against decoy peptides is considered incorrect and can be used to generate a reference null 
distribution to assign significance values to the peptide-spectrum matches. For peptide-spectrum 
matches, permutation p-values were computed using a k-permuted decoy database that indicated 
the probability that a match between peptide and spectra is due to chance. In a recent study, the 
performance of the permuted approach was evaluated using Whole sequence and Ends k-permuted 
decoy databases that provided better sensitivity and discrimination in the performance of the 
different scores or indicators reported by the three database search programs, respectively.
88
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In the Whole sequence k-permuted decoy databases, the k number of complete peptide 
sequences that were within 3.0 Da of the spectrum masses were randomly generated without 
replacement using a python script. For each position in the decoy peptides, the amino acids were 
randomly sampled with replacement from a list of 19 standard amino acids. The leucine and 
isoleucine were treated as isobaric amino acids and only Leucine was used to generate decoy 
peptides. For each experimental spectrum a separate decoy database was created containing 1 x 10
5
 
decoy peptides. The consideration of separate decoy databases for each spectrum can reduce the 
overall search time when multiple database search programs are considered. This strategy of 
permuted decoy database creation can be applied to any type of peptides, experiments, and 
database search programs.  
The tandem mass spectra were searched against the k-permuted decoy peptide databases 
using OMSSA with enzymatic settings that prevented the cleavage of the provided peptide 
sequences. For each spectrum, the peptide matches in the k-permuted database that were identical 
in terms of match scores (i.e., Poisson Lambda, the number of matched ions, p-value, and E-value) 
and had masses within 3 Da of each other were treated as homeometric
86
 matches. The 
homeometric matches were counted only once in calculation of permutation p-values. The problem 
of zero p-values was avoided by using the following formula for the p-value computation with plus 
one representing target peptide score that is always equal to itself:
73
 
        
  ∑              
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Where t(r) is the score for the permuted peptides, t(s) is the score for the target peptides, 
and N is the effective database size for each particular spectrum. The two-fold search strategy was 
implied.  
a) Tandem mass spectra were searched against the target database using OMSSA and 
the permutation p-values were computed for the OMSSA’s E-values assigned to 
each peptide-spectrum match using k-permuted decoy databases. 
b) Tandem mass spectra were searched against the concatenated target-reversed 
database using OMSSA and the permutation p-values were calculated for the 
OMSSA’s E-values of the peptide-spectrum matches using k-permuted decoy 
databases.  
PERFORMANCE EVALUATIONS: FDR AND ROC CURVES 
For the two strategies, the performance (i.e., peptide detection at a specific FDR-based 
threshold) of the OMSSA E-value and permutation approach was compared at a 5% FDR. Only 
the best hit for each spectrum was considered in the FDR calculation and performance evaluation. 
The peptide-spectrum matches were arranged in the increasing order of their E-values and 
permutation p-values to compute the FDR. The significance value at which FDR was immediately 
below 5% was selected as thresholds. 
For the target database search strategy, FDR was calculated with the assumption that the 
incorrect hits in the forward database are already known. This was accomplished using 671 
annotated spectra with known sequence identities, while the remaining 5,135 spectra with 
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unknown peptide sequences were not considered in FDR calculation. The FDR was estimated with 
the following formula: 
     
  
     
           
 Where FP (false positive) and TP (true positives) were the number of incorrect and correct 
peptides hits with significance values below the threshold (i.e., significant matches), while TN 
(true negatives) and FN (false negatives) were the number of incorrect and correct peptide hits with 
significance values above the threshold (i.e., insignificant matches). 
For the concatenated target-reversed database, FDR was calculated with the assumption 
that the incorrect hits in the forward database are not known (common case in MS/MS 
proteomics). All 5,806 spectra were considered in the FDR calculation using the following 
formula: 
     
                
                 
          
Where, number of decoys and targets represent the number of reversed and target peptides 
receiving significance values more significant than the threshold. The selected FDR formula 
produces less conservative FDR estimates than the (2.decoys) / (target + decoy) formula.
92
 This 
procedure allowed the classification of 671 annotated spectra into TP, FN, TN, and FP at a 
particular score threshold. 
Standard ROC curves were also used to compare the performance of the OMSSA’s E-value 
and permutation approach. ROC curves were generated in OriginPro (version 8.6; 
http://www.originlab.com/). Plots showed tradeoff between Sensitivity (fraction of correct 
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significant peptide identifications among all correct identifications) and 1-specificity (fraction of 
incorrect significant identifications among all incorrect identifications) across different significance 
thresholds and provided a useful way to compare performance of the two approaches. 
4.5 RESULTS AND DISCUSSION 
The sensitivity (i.e., number of correct peptides matched at a given FDR threshold), and the 
significance levels of the peptide assignments to validated tandem mass spectra of the tryptic 
peptides obtained from the serum and plasma protein samples were evaluated. The peptide matches 
were filtered with 5% FDR, where FDR was calculated from the best hits for the tandem mass 
spectra matching in the target database and target-reversed concatenated databases. The peptide 
identification rates were compared between the OMSSA’s E-value indicator (best indicator for the 
OMSSA based on previous two chapters) and permuted significance levels attained from the k-
permuted decoy database using E-value indicator. The performance of the two approaches was 
compared in the target database and target-reversed concatenated database. The results were 
further verified by conventional ROC curves that highlighted the performance (i.e., tradeoff 
between Sensitivity vs. 1-Specficity) of the OMSSA’s E-value and permutation approach 
regardless of any specific threshold based on false positive rate. 
SENSITIVITY OF THE OMSSA’S E-VALUE IN THE STANDARD TARGET DATABASE 
Sensitivity is a measure of the ability of the database search program to correctly match 
tandem mass spectra to peptide sequences in the database.
20
 Table 4.1 summarizes the number of 
annotated spectra that provided correct and incorrect matches in the target database.  
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The known peptide identities of the 671 annotated tandem spectra in this dataset were 
compared against the top hit assigned to each spectrum by OMSSA to classify them as correct and 
incorrect matches. In the target database, OMSSA correctly matched 469 (69.90%) peptides 
irrespective of the match significance levels. Of the remaining 202 incorrectly matched tandem 
mass spectra, 49 spectra were not detectable for the OMSSA either due to the absence of candidate 
peptides from the RefSeq database (39) or search parameter settings (10 spectra with N-terminal 
carbamylation). Any peptide match to these spectra was treated either as false positive or true 
negative identification based on significance threshold during the estimation of FDR. Spectra with 
no candidate peptides in the RefSeq database correspond to immunoglobulin genes that undergo 
extensive rearrangement and protein RefSeqs are not available for these genes. The remaining 153 
spectra provided incorrect matches even in the presence of candidate peptides in the target 
database. Most of these spectra were incorrect either due to low intensity of the signal peaks 
relative to the noise peaks (high intensity noise peaks get preference over low intensity signal 
peaks due to filtering steps of OMSSA) or presence of better scoring modified peptides. 
The sensitivity of the OMSSA’s E-value was examined at a 5% FDR. In MS/MS based 
analysis, usually the incorrect matches in the target database are not known and the FDR is 
estimated using target-decoy approach or mixture model approach.
41
 However, due the presence of 
annotated spectra in the dataset, the FDR is calculated directly as the proportion of incorrectly 
matched annotated spectra in the target database using formula one (see materials and methods 
section). For the calculation of FDR, the peptide matches were arranged in the ascending order of 
OMSSA’s E-value and permutation p-values. The value at which the FDR was immediately below 
5% was selected as the threshold.  
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Table 4.2 summarizes the number of true positive, false negative, true negative, false 
positive identifications at a 5% FDR for the OMSSA’s E-value in the target database. OMSSA 
significantly detected 384 (81.88%) peptide identifications out of 469 at s 5% FDR. The 85 
peptides that were not significantly detected had precursor charge state of +1 (54 peptides) and +2 
(31), while all correctly matched peptides with +3 precursor charge state were significantly 
detected at 5% FDR. The false negative peptides had E-values > 1 x 10
-1 
and less number of 
matched fragment ions (<13) which made them indistinguishable from other incorrect matches in 
the target database. This was consistent with the previous study indicating that with insufficient 
number of matched fragment ions (either due to missing ions, small peptide size etc.,) the 
significance values of the OMSSA tends to increase (i.e., become less significant).
16
 Of the 85 
insignificant peptides, 100%, 100%, 94%, 62%, 45%, 41%, 20%, and 25% had 5, 6, 7, 8, 9, 10, 11, 
and 12 number of matched fragment ions. False negative peptides showed more overlap with the 
true negatives and false positives in terms of OMSSA E-values which made those peptides 
insignificant using the OMSSA E-values. 
SENSITIVITY OF THE PERMUTATION APPROACH IN STANDARD TARGET DATABASE 
The E-value indicator was considered in this study due to its higher sensitivity and 
discriminatory power than the other peptide-spectrum match quality indicators in the previous 
studies (chapter II and III). OMSSA’s E-values of around 37% correctly matched annotated 
peptides were more significant than the ones obtainable with the k-permuted decoy database size 
used in this study. These 37% peptides were also significant with the k-permuted decoy database. 
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Overall, k-permuted showed better performance for the false negative identifications produces by 
the standard OMSSA’s E-value due to overlap with true negatives and false positives. 
Table 4.2 summarizes the number of TP, FN, TN, FP identifications at a 5% FDR for the 
k-permuted decoy database. At a 5 % FP rate, the k-permuted decoy database identified 417 
(88.91%) of the annotated peptides correctly matched by the OMSSA database search program. 
The sensitivity of the k-permuted decoy database improved with the increasing number of matched 
fragment ions. Peptide detection rate was 0%, 42%, 12%, 52%, 68%, 79%, 96%, 97%, and 100% 
for peptides with 5, 6, 7, 8, 9, 10, 11, 12, and 13 matched fragment ions, respectively. All peptides 
with +3 precursor charge state were significantly detected, while 38 and 14 peptides were missed 
by the k-permuted decoy database with precursor charge states of +1 and +2, respectively.  
Consistent with our previous studies, accurate permutation p-values for the E-value 
indicator could be estimated with smaller number of permutations (≈ 105). The large E-values (less 
significant) assigned to the peptide matches in the target database allowed more decoy peptides to 
receive equal or more extreme values than the target peptides even with less number of 
permutations, thus separating correct and incorrect matches in better fashion. This is because the 
target peptide matches with less number of matched ions and less intense fragment ion peaks can 
receive higher E-values which in turn can make target database matches with extremely large E-
values non-significant.  
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COMPARISON OF PERFORMANCE IN THE TARGET DATABASE 
Table 4.3 summarizes the log10-transformed significance levels of the OMSSA’s E-values 
for the peptides that were significantly detected by the OMSSA E-value and k-permuted decoy 
database, k-permuted decoy database only, OMSSA E-value only, and not detected by any 
approach.  
Comparison of the peptide identifications between the OMSSA E-value and k-permuted 
decoy database indicated that 378, 39, and 6 peptides were significantly detected by the two 
approaches, only k-permuted decoy database, and only OMSSA E-value, respectively. Consensus 
among approaches was lower for the small and large peptide matches with fewer than 13 matched 
fragment ions. The OMSSA E-value and k-permuted decoy database detected 0%, 0%, 0.06%, 
31%, 45%, 55%, 80%,75%, 93% peptides with 5, 6, 7, 8, 9, 10, 11, 12, and 13 number of matched 
fragment ions. The 46 peptides were not detected by any approach. The peptides that were not 
significant across both approaches had less number of matched ions (ranging between 5 to 12) and 
large OMSSA’s E-values (mean=23.89, std. dev=51). Due to large E-values and less number of 
matched ions the more permuted decoy peptides had extreme E-values than the correct matches. 
The peptides with extreme E-values (especially short peptides with +1 charge state) were not 
distinguishable from other incorrect matches in the target database.  
Figure 4.1 depicts the ROC curve comparison between the OMSSA’s E-value indicator 
and permutation p-value approach. Roc curves shows the effectiveness of each match indicators 
across different significance thresholds by allowing investigation of tradeoff between true positive 
rate (sensitivity) and false positive rate (1-specificity). The diagonal line from lower left corner to 
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the upper left corner in the curve indicates the usefulness of the two approaches. The curves above 
the diagonal lines denote that the discrimination between correct and incorrect peptide 
identifications provided by the approaches was not due to chance. The area under the curve (AUC) 
given in plot provides information about the discriminatory power (value close to one shows good 
power) of each approach across different significance thresholds. 
The curves depicts the tradeoff between the true positive rate and false positive rate across 
different thresholds for the OMSSA’s E-value indicator and permutation p-value calculated from 
the E-value indicator using k-permuted decoy database. Overall, the k-permuted decoy database 
performed better than the OMSSA E-value in the target database. The AUC indicating 
effectiveness for the k-permuted decoy database and OMSSA E-value in separating correct from 
incorrect matches was around 0.95 and 0.94, respectively. The false positive rate of the OMSSA E-
value was slightly lower than the k-permuted decoy database when the sensitivity was below 68%. 
However, false positive rate of the OMSSA E-value increased with slight increase in sensitivity of 
the peptide identifications. The performance of k-permuted decoy database and OMSSA E-value 
converged around sensitivity of 79%. The k-permuted decoy database achieved higher sensitivity 
(around 89%) while keeping false positive rate below 5% than OMSSA E-value with sensitivity 
around 82%. 
SENSITIVITY OF THE PEPTIDE IDENTIFICATION USING TARGET-REVERSE APPROACH 
In MS/MS analysis, target-decoy search strategy is commonly used to estimate the FDR as 
the peptide identities for the incorrect matches in the target database are not known. The target-
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decoy strategy is easy to implement and is based on the assumption that the incorrect matches in 
the target database and decoy database have identical score distributions. In this study, protein 
sequences in the target database were reversed and appended to the target database to conduct 
combined target-decoy database search. This is because the combined search strategy is considered 
to produce less conservative FDR estimates.
92
 The 5,806 spectra were searched against the 
combined database and using the best hit for each spectrum was considered. The permutation p-
values for the OMSSA E-values were calculated using k-permuted decoy database as the ratio of 
permuted peptides receiving E-values as extreme as the E-value of the hits in the target-decoy 
database. The performance of the OMSSA E-value and k-permuted decoy database was compared 
in terms of sensitivity and overlap among peptide identifications in the target and permuted 
databases at 5% FDR, where FDR was calculated as the ratio of decoy and target matches at 
different significance threshold.  
Table 4.1 summarizes the number of annotated spectra with correct and incorrect peptide 
assignments in the target-reverse decoy database across three precursor charge states. OMSSA 
correctly matched 459 (68.41%) annotated spectra. The target-reverse database reduced the 
number of correct peptide identifications by 1% relative to the target only database. Seven peptides 
with +1 charge state that were not correctly matched by the OMSSA in the target-reverse database 
were not significantly detected by the OMSSA in the target database at 5% FDR. This could be 
one of the reasons for the apparent reduction in the number of false negative peptides in the target-
reverse database relative to the target only database in addition to the increase in number of 
available spectra for the calculation of FDR.  
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Table 4.4 summarizes the number of TP, FN, TN, and FP matches for the 671 annotated 
spectra using OMSSA’s E-value and k-permuted database. The OMSSA E-value significantly 
detected 84.10% peptides out of the 459 correctly annotated spectra at 5% FDR based threshold. 
Consistent with the target database results, about 92% true positives matches had E-values < 1 x 
10
-1
, while false negatives had E-values > 1 x 10
-1 
and showed more overlap with the true negatives 
and false positives. The k-permuted database detected 87.15% of the correctly matched annotated 
peptides. Compared with the OMSSA’s E-value, the k-permuted database had higher sensitivity 
and specificity (33% less false positives). Consistent with the target database, k-permuted approach 
detected more peptides that showed higher overlap with false positives and true negatives using 
OMSSA’s E-values. Furthermore, OMSSA’s E-value and k-permuted decoy database also 
significantly detected 566 and 594 unannotated spectra which could be either false positives or true 
positives but there is no assurance about these results.  
4.6 CONCLUSIONS 
The present study demonstrated that the k-permuted decoy database can be used for both 
peptide matches coming from the target database and commonly used target-decoy database search 
strategy. The peptide-spectrum matches were filtered with false discovery rate calculated in two 
different ways. The results indicated that in both databases the k-permuted database had higher 
specificity (less false positives) than the standard approach implemented in the OMSSA program.   
The k-permuted decoy database allowed detection of more annotated peptides in both the 
target database and target-reverse database relative to the OMSSA E-value at a fixed false 
discovery rate of 5%. Better detection rate was achieved by separating borderline correct matches 
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with large E-values (less significant) from incorrect matches. The area under the ROC curves was 
slightly better for the k-permuted decoy database. The study demonstrated that the k-permuted 
decoy database can be integrated with any database search program and current standards in 
MS/MS based analysis. 
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4.7 FIGURES 
 
Figure 4.1. ROC curves for match indicators in the target and permuted databases. Plot compares 
discriminatory powers of target database versus permuted database using permuted p-values from 
the OMSSA’s E-value indicators against target database E-value. 
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4.8 TABLES 
Table 4.1. The number of correctly and incorrectly matched annotated spectra in the target and 
concatenated target-reverse databases, irrespective of the match significance levels across three 
precursor charge states.  
Peptide hits for the 
annotated spectra 
Target database Concatenated target-reverse database 
Total 
spectra 
Precursor charge state 
distribution  
Total 
spectra 
Precursor charge state 
distribution 
+1 +2 +3 +1 +2 +3 
Matched 469 98 303 68 459 92 300 67 
Misidentified 202 120 57 25 212 126 60 26 
Total 671 218 360 93 671 218 360 93 
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Table 4.2. Sensitivity of the OMSSA’s E-value and k-permuted decoy database at 5% False 
Discovery Rate when spectra were searched against standard target database. 
Approacha Total spectra 5% False Discovery Rate (FDR)b 
  TPc FN TN FP Threshold 
OMSSA’s E-value 671 384 85 182 20 0.21557 
Permutation 671 417 52 181 21 1.995e-5 
a) 
E-value: OMSSA’s E-value; Permutation: p-value computed using OMSSA’s E-value; 
b) 
FDR: FP/TP+FP; 
c)
 TP: number of correctly matched peptides significant at 5% FDR; FN: number of correctly 
matched peptides not significant at 5% FDR; TN: number of incorrectly matched peptides not 
significant at 5% FDR; FP: number of incorrectly matched peptides significant at 5% FDR; 
Threshold: significance threshold for the 5% FDR. 
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Table 4.3. The number of spectra significantly detected by both OMSSA’s E-value and k-
permuted decoy database, k-permuted decoy database only, OMSSA’s E-value only, and not 
detected by any approach in the target database at a false discovery rate of 5%.  
Log10 E-value Permuted & 
OMSSA’s E-value 
Permuted 
approach only 
OMSSA’s E-value 
only 
Not significant in 
both approaches 
-3 0 0 0 0 
-2 0 0 0 3 
-1 0 3 0 13 
0 13 36 1 30 
1 34 0 3 0 
2 46 0 2 0 
3 39 0 0 0 
4 36 0 0 0 
5 36 0 0 0 
6 174 0 0 0 
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Table 4.4. Sensitivity of the OMSSA’s E-value and k-permuted decoy database at 5% False 
Discovery Rate when spectra were searched against target-reverse combined database. 
Approacha Total 
spectra 
Target database 
matchesb 
Reverse database 
matchesc 
 5% False Discovery Rate 
(FDR)d 
TPe FN TN FP Unknown 
OMSSA’s E-
value 
5806 3834 1972 386 73 173 39 566 
Permutation 5806 3834 1972 400 59 186 26 594 
a) 
E-value: OMSSA’s E-value; Permutation: p-value computed using OMSSA’s E-value; 
b) 
The number of spectra with peptide matches from the target database. 
c) 
The number of spectra with peptide matches from the reverse database. 
d) 
FDR: #reverse/#targets; based on the assumption that usually incorrect matches in the target 
database are not known, the unknown spectra with match in target database were treated as target 
while calculating FDR. 
e)
 TP: number of correctly matched peptides significant at 5% FDR; FN: number of correctly 
matched peptides not significant at 5% FDR; TN: number of incorrectly matched peptides not 
significant at 5% FDR; FP: number of incorrectly matched peptides significant at 5% FDR; 
Unknown: unannotated spectra those were significant at 5% FDR; Threshold: significance 
threshold for the 5% FDR. 
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CHAPTER V: CONCLUSION 
The database search programs are commonly used to identify neuropeptides and proteins in 
tandem mass spectrometry experiments. In MS/MS analysis, typical challenges for the database 
search programs include failure to correctly identify tandem mass spectra and discriminate correct 
from incorrect identifications. Previous studies have shown that the programs designed for protein 
identification (usually one unique peptide matched with high confidence is enough to identify 
protein) are not optimized for the identification of neuropeptides and short peptides present in 
biological sample.
16
 For the ideal simulated tandem spectra containing all possible fragment ions, 
the database search programs can correctly assign peptide sequences to most tandem mass spectra. 
However, accurate assignment of the match significance levels remains challenging due to spectral 
quality issues and limitations of the parametric distribution approaches in programs for the shorter 
peptides.  
In my studies, permutation testing was used to overcome the limitations associated with the 
parametric approaches already implemented in the database search programs. Three studies were 
conducted with the overall aims: (a) to develop and integrate permutation resampling approach 
with the database search programs; (b) to identify the match indicators that provide optimal 
performance within and across programs; and (c) to evaluate the classification performance of the 
approach relative to the already implemented approaches in the database search programs. The 
permutation databases based on the complete permutations and terminal permutations of the 
peptide sequences were developed and performance of various scores within and across programs 
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was tested. The results provided us an insight about suitability of the various scores in each 
program to be used for computation of significance values.  
Resampling approach can be used to validate the suitability of the significance estimation 
approached implemented in the database search programs. The magnitude of the scores is reduced 
by factors such as spectral complexity and low signal-to-noise ratio even in presence of correct 
matches, which in turn have an effect on the match significance values. These spectral quality 
issues had larger impact on the significance estimation approaches already implemented in the 
programs relative to the resampling approach. The approach improved peptide detection rate in 
Crux and X! Tandem programs which underestimated significance values with parametric 
approaches leading to reduction in the peptide identifications. Furthermore, the permutation testing 
validated the suitability of the significance estimation approach implemented in OMSSA for the 
neuropeptides. 
Additionally, the resampling approach provides comparable basis for benchmarking 
various database search programs. The same peptide identifications from the different database 
search programs are less likely to be comparable due to difference in significance estimation 
approaches using standard ways to adjust for the multiple hypotheses testing. A common approach 
in MS/MS studies is to use target-decoy database search strategy to compute significance 
thresholds based on certain level of false discovery rate to control for multiple hypothesis testing. 
On the other hand, resampling approach allows computation of significance levels for various 
programs and scores in the same fashion, which allows their benchmarking using standard 
threshold adjustment procedures for multiple hypothesis testing. This can be useful to save 
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computational search time which increases when spectra are searched against target-decoy 
databases. 
Consensus approach (use of multiple programs) assures that the peptide matches are less 
likely to be false positives. Our studies demonstrate that the programs show less agreement for the 
peptide identifications at more stringent thresholds with already implemented significance 
estimation approaches. The resampling approach improves consensus among programs due to 
higher peptide detection rate for the Crux and X! Tandem that previously underestimated 
significance values. Furthermore, the resampling approach confirms the previous notion that some 
scoring functions are better suited for peptide identification than other programs.  
The database search programs assign peptide matches to tandem mass spectra even when 
appropriate candidate peptides are missing from the database. This requires that significance 
estimation approaches should be able to provide good separation between correct and incorrect 
peptide identifications. The results demonstrated that the resampling approach performs better in 
discriminating correct peptides matches with less than 13 matched fragment ions from other 
incorrect matches. 
The permutation testing provides more accurate estimates of the null distribution, where the 
null distribution is formed by either complete random peptides or terminal permutations of the 
peptides that fall within a certain mass tolerance range of each spectrum. The two types of 
permuted decoy databases provided enough number of target alike decoy peptides to discriminate 
the performance of poor match indicators from the strong indicators of the peptide match. Some 
scores or indicators within and across programs had lower peptide detection rate regardless of the 
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type of the permuted decoy database. Terminal permutations generated more decoy peptides that 
can receive more extreme scores than the target database matches which in turn reduced the 
peptide detection using indicators within and across database search programs.  
The availability of the open source database search programs to proteomics and 
bioinformatics community is important to evaluate and refine their scoring functions. The ability to 
retrieve and test a set of intermediate and final match indicators from the database search programs 
provides useful information about the relative strengths of various match indicators within and 
across programs. Model free property of the k-permuted decoy database allows consideration of 
the multiple match indicators in confidently identifying peptides that are borderline significant. 
Furthermore, the sharing of source code to generate k-permuted decoy database will be beneficial 
for the proteomics community to further explore the biological, statistical, and computational basis 
of the approach for the other database search programs and spectral identification approaches.   
Future studies are needed to uncover the impact of target peptide amino acid composition 
on the significance levels estimation using k-permuted decoy databases. Furthermore, a study 
about assigning significance values to protein matches rather than the spectrum matches needs to 
be undertaken. 
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